These	O	DET	O
findings	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
therapeutic	O	ADJ	B
strategies	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
immunosuppressants	O	NOUN	B
targeting	O	VERB	B
the	O	DET	O
CD28	B-protein	NOUN	B
costimulatory	O	ADJ	I
pathway	O	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
following	O	VERB	O
T-cell	O	NOUN	B
stimulation	O	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
largely	O	ADV	O
through	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
to	O	PART	O
two	O	NUM	O
adjacent	O	ADJ	B
kappa	B-DNA	NOUN	O
B	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
four	O	NUM	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
:	O	PUNCT	O
a	O	DET	O
single	O	ADJ	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
purine-rich	B-DNA	ADJ	B
binding	I-DNA	VERB	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
PuB1	B-DNA	NOUN	B
and	O	CCONJ	O
PuB2	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
pets	B-DNA	NOUN	B
site	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
identified	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
cis-acting	B-DNA	ADJ	B
element	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
,	O	PUNCT	O
immediately	O	ADV	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
designated	O	VERB	O
peri-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
.	O	PUNCT	O


Understanding	O	VERB	O
the	O	DET	O
monocyte-specific	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
peri-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
factor	I-protein	NOUN	I
may	O	AUX	O
ultimately	O	ADV	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
different	O	ADJ	O
role	O	NOUN	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
play	O	VERB	O
in	O	ADP	O
HIV	O	NOUN	B
pathogenesis	O	NOUN	B
.	O	PUNCT	O


E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
induces	O	VERB	O
susceptibility	O	NOUN	B
to	O	PART	O
killing	O	VERB	B
by	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
following	O	VERB	O
immortalization	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
adenovirus	O	NOUN	B
infection	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
products	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
during	O	ADP	O
infection	O	NOUN	B
was	O	AUX	O
not	O	PART	O
explained	O	VERB	O
by	O	ADP	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
viral	O	ADJ	B
infection	O	NOUN	I
on	O	ADP	O
otherwise	O	ADV	O
susceptible	O	ADJ	B
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
effects	O	NOUN	O
on	O	ADP	O
class	B-protein	NOUN	B
I	I-protein	NUM	I
MHC	I-protein	NOUN	I
antigen	I-protein	NOUN	I
expression	O	NOUN	B
on	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
differential	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
E1A	B-protein	NOUN	B
expression	O	NOUN	B
on	O	ADP	O
the	O	DET	O
cytolytic	O	ADJ	B
phenotypes	O	NOUN	B
of	O	ADP	O
infected	O	ADJ	B
and	O	CCONJ	O
stably	O	ADV	B
transfected	O	VERB	B
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
provide	O	VERB	O
an	O	DET	O
effective	O	ADJ	B
immunologic	O	ADJ	B
barrier	O	NOUN	I
against	O	ADP	O
the	O	DET	O
in	O	X	B
vivo	O	X	I
survival	O	NOUN	B
and	O	CCONJ	O
neoplastic	O	ADJ	B
progression	O	NOUN	B
of	O	ADP	O
E1A-immortalized	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
that	O	PRON	O
may	O	AUX	O
emerge	O	VERB	O
from	O	ADP	O
the	O	DET	O
reservoir	O	NOUN	B
of	O	ADP	O
persistently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
host	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
interacts	O	VERB	O
with	O	ADP	O
non-polymorphic	B-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
major	B-protein	ADJ	O
histocompatibility	I-protein	NOUN	O
complex	I-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
molecules	I-protein	NOUN	O
on	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
contributes	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CD4	B-protein	NOUN	B
triggering	O	NOUN	B
on	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activating	O	NOUN	O
signals	O	NOUN	B
in	O	ADP	O
a	O	DET	O
lymphoma	O	NOUN	B
model	O	NOUN	I
using	O	VERB	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
recognize	O	VERB	O
different	O	ADJ	O
CD4	B-protein	NOUN	B
epitopes	I-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
different	O	ADJ	O
anti-CD4	B-protein	ADJ	B
mAb	I-protein	NOUN	B
or	O	CCONJ	O
HIV-1	B-protein	NOUN	B
gp120	I-protein	NOUN	B
could	O	AUX	O
all	O	DET	O
trigger	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
p56lck	B-protein	NOUN	I
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Shc	B-protein	NOUN	B
adaptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
signals	O	NOUN	B
to	O	PART	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
differed	O	VERB	O
significantly	O	ADV	O
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
identify	O	VERB	O
functionally	O	ADV	O
distinct	O	ADJ	O
epitopes	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ras/protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
chickens	O	NOUN	B
,	O	PUNCT	O
estrogens	O	NOUN	B
stimulate	O	VERB	O
outgrowth	O	NOUN	B
of	O	ADP	O
bone	B-cell_type	NOUN	B
marrow-derived	I-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	I
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
delay	O	VERB	B
their	O	PRON	O
maturation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
repressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
repression	O	NOUN	B
is	O	AUX	O
reversible	O	ADJ	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
4-hydroxytamoxifen	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
coimmunoprecipitation	O	NOUN	B
experiments	O	NOUN	I
using	O	VERB	O
transfected	O	VERB	B
COS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
ER	B-protein	NOUN	B
associate	O	VERB	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
estrogens	O	NOUN	B
exert	O	VERB	O
effects	O	NOUN	B
on	O	ADP	O
erythropoiesis	O	NOUN	B
by	O	ADP	O
modulating	O	VERB	O
GATA-1	B-protein	NOUN	B
activity	O	NOUN	B
through	O	ADP	O
protein-protein	O	ADJ	B
interaction	O	NOUN	I
with	O	ADP	O
the	O	DET	O
ER	B-protein	NOUN	B
.	O	PUNCT	O


Mouse	B-DNA	NOUN	B
interleukin-2	I-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Interleukin-1	B-protein	NOUN	B
and	O	CCONJ	O
interleukin-2	B-protein	NOUN	B
control	O	VERB	O
transcription	O	NOUN	O
via	O	ADP	O
distinct	O	ADJ	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
map	O	VERB	B
the	O	DET	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
that	O	PRON	O
mediate	O	VERB	O
interleukin	O	NOUN	B
responsiveness	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
using	O	VERB	O
a	O	DET	O
thymic	B-cell_line	ADJ	B
lymphoma-derived	I-cell_line	ADJ	I
hybridoma	I-cell_line	NOUN	I
(	O	PUNCT	O
PC60	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


IL-1	B-protein	NOUN	B
induces	O	VERB	B
a	O	DET	O
rapid	O	ADJ	B
,	O	PUNCT	O
protein	O	NOUN	B
synthesis-independent	O	ADJ	B
appearance	O	NOUN	B
of	O	ADP	O
IL-2R	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
that	O	PRON	O
is	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
inhibitors	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
show	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
promoter-proximal	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
contribute	O	VERB	O
to	O	PART	O
IL-1	B-protein	NOUN	B
responsiveness	O	NOUN	B
,	O	PUNCT	O
most	O	ADV	O
importantly	O	ADV	O
an	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
mouse	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
segment	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
an	O	DET	O
IL-2-inducible	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
lies	O	VERB	O
within	O	ADP	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
becomes	O	VERB	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
hypersensitive	O	ADJ	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
which	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
focuses	O	VERB	O
on	O	ADP	O
the	O	DET	O
roles	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoietic	O	ADJ	B
lineage	O	NOUN	I
commitment	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
brief	O	ADJ	O
introduction	O	NOUN	O
to	O	PART	O
lineage	O	NOUN	B
commitment	O	NOUN	B
and	O	CCONJ	O
asymmetric	O	ADJ	B
cell	O	NOUN	I
division	O	NOUN	I
is	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
methods	O	NOUN	B
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
important	O	ADJ	O
in	O	ADP	O
specifying	O	VERB	O
hematopoietic	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
types	I-cell_type	NOUN	I
.	O	PUNCT	O


Next	O	ADV	O
is	O	AUX	O
presented	O	VERB	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
embryonic	B-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
hematopoietic	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
expression	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
targeted	O	VERB	B
gene	O	NOUN	B
disruption	O	NOUN	B
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
and	O	CCONJ	O
others	O	NOUN	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
EBV	O	NOUN	B
can	O	AUX	O
also	O	ADV	O
infect	O	VERB	B
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


ZEBRA	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
also	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
by	O	ADP	O
immunoprecipitation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
EBNA-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
was	O	AUX	O
transcribed	O	VERB	B
from	O	ADP	O
the	O	DET	O
Fp	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
from	O	ADP	O
the	O	DET	O
Cp/Wp	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
which	O	DET	O
is	O	AUX	O
used	O	VERB	O
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Transcripts	O	NOUN	B
encoding	O	VERB	B
gp350/220	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
major	B-protein	ADJ	O
coat	I-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
EBV	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
find	O	VERB	O
any	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
LMP-2A	B-DNA	NOUN	B
or	O	CCONJ	O
EBER-1	B-DNA	NOUN	B
loci	I-DNA	NOUN	I
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
de	O	X	B
novo	O	X	I
EBV	O	NOUN	B
infection	O	NOUN	B
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
differs	O	VERB	O
from	O	ADP	O
infection	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Rather	O	ADV	O
,	O	PUNCT	O
EBV	O	NOUN	B
remains	O	VERB	O
in	O	ADP	O
a	O	DET	O
linear	O	ADJ	B
configuration	O	NOUN	I
from	O	ADP	O
which	O	DET	O
replicative	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
are	O	AUX	O
transcribed	O	VERB	B
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
purification	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
Stat	I-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
interleukin-2	B-protein	NOUN	B
.	O	PUNCT	O


Several	O	ADJ	O
recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
implicated	O	VERB	O
Jak	O	NOUN	B
kinases	O	NOUN	I
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
purified	O	VERB	O
these	O	DET	O
activities	O	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
principal	O	ADJ	B
IL-2-inducible	B-protein	ADJ	O
component	I-protein	NOUN	O
bears	O	VERB	O
significant	O	ADJ	O
relatedness	O	NOUN	B
to	O	PART	O
a	O	DET	O
prolactin-induced	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
first	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
sheep	B-cell_type	NOUN	B
mammary	I-cell_type	ADJ	B
gland	I-cell_type	NOUN	I
tissue	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesize	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
hStat5	B-protein	NOUN	B
,	O	PUNCT	O
helps	O	VERB	O
govern	O	VERB	O
the	O	DET	O
biological	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
during	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
,	O	PUNCT	O
through	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
UDG	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
,	O	PUNCT	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
E2F-1	B-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
UDG	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
through	O	ADP	O
several	O	ADJ	O
E2F	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
cyclin-like	B-protein	ADJ	B
UDG	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
and	O	CCONJ	O
E2F	B-protein	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
UDG	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
transient	O	ADJ	B
transfection	O	NOUN	O
assay	O	NOUN	O
result	O	VERB	O
in	O	ADP	O
the	O	DET	O
down-regulation	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
through	O	ADP	O
elements	B-DNA	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
E2F	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


Cellular	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
production	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
two	O	NUM	O
interleukins	B-protein	NOUN	B
(	O	PUNCT	O
ILs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
potent	O	ADJ	O
inducers	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
LGL	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
NK3.3	I-cell_line	NOUN	B
derived	O	VERB	O
from	O	ADP	O
human	B-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
responds	O	VERB	O
to	O	PART	O
both	O	CCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
cytoplasmic	O	ADJ	B
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
when	O	SCONJ	O
used	O	VERB	O
together	O	ADV	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
synergized	O	VERB	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
this	O	DET	O
synergy	O	NOUN	B
was	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
an	O	DET	O
increased	O	VERB	B
accumulation	O	NOUN	B
and	O	CCONJ	O
stability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
GM-CSF	I-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
both	O	CCONJ	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
and	O	CCONJ	O
genistein	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
could	O	AUX	O
suppress	O	VERB	B
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
but	O	CCONJ	O
CsA	O	NOUN	B
was	O	AUX	O
generally	O	ADV	O
inactive	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
distinct	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
NK3.3	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
may	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
model	O	NOUN	B
for	O	ADP	O
dissecting	O	VERB	B
the	O	DET	O
biochemical	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
events	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
these	O	DET	O
pathways	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
functional	O	ADJ	B
T-cell	B-protein	NOUN	O
receptor	I-protein	NOUN	O
signaling	O	NOUN	O
pathway	O	NOUN	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
p95vav	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
structural	B-protein	ADJ	B
motifs	I-protein	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
Src	B-protein	NOUN	B
homology	I-protein	NOUN	B
2	I-protein	NUM	I
,	I-protein	PUNCT	O
Src	I-protein	NOUN	B
homology	I-protein	NOUN	O
3	I-protein	NUM	O
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
pleckstrin	I-protein	NOUN	B
homology	I-protein	NOUN	I
domains	I-protein	NOUN	I
and	O	CCONJ	O
a	O	DET	O
putative	B-protein	ADJ	B
guanine	I-protein	NOUN	I
nucleotide	I-protein	NOUN	I
exchange	I-protein	NOUN	I
domain	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
p95vav	B-protein	NOUN	B
synergizes	O	VERB	B
with	O	ADP	I
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
inducing	O	VERB	O
NFAT-	O	NOUN	B
and	O	CCONJ	O
interleukin-2-dependent	O	ADJ	B
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p95vav	B-protein	NOUN	B
-induced	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
mimicked	O	VERB	O
by	O	ADP	O
Ras	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
though	O	SCONJ	O
its	O	PRON	O
function	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
Ras	B-protein	NOUN	B
and	O	CCONJ	O
Raf	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
p95vav	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
influence	O	VERB	B
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
or	O	CCONJ	O
increases	O	VERB	B
in	O	ADP	O
cytoplasmic	O	ADJ	B
free	O	ADJ	I
calcium	O	NOUN	I
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
promoter	O	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
AML1-related	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
PEBP2	B-protein	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
alpha	B-DNA	NOUN	B
A	I-DNA	NOUN	I
and	O	CCONJ	O
alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	B
the	O	DET	O
alpha	B-protein	NOUN	B
subunit	I-protein	NOUN	I
.	O	PUNCT	O


alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
is	O	AUX	O
the	O	DET	O
mouse	B-DNA	NOUN	B
homologue	I-DNA	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
AML1	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
detected	O	VERB	B
at	O	ADP	O
the	O	DET	O
breakpoints	O	NOUN	B
of	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
8	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
t	O	NOUN	O
(	O	PUNCT	O
3	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
myeloid	O	ADJ	B
leukemias	O	NOUN	I
.	O	PUNCT	O


PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	I
A1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
enhanced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter-driven	I-DNA	ADJ	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
in	O	ADP	O
unstimulated	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
12-O-tetradecanoylphorbol	I-cell_line	NOUN	O
13-acetate/phytohemagglutinin-stimulated	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B2	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
/alpha	B-protein	NOUN	I
B2	I-protein	NOUN	I
ratio	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
further	O	ADJ	O
studies	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
precise	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
PEBP2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
GM-CSF	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
findings	O	NOUN	B
suggested	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
relative	O	ADJ	O
ratio	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
PEBP2	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


IFN-gamma	B-protein	NOUN	B
priming	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
enhances	O	VERB	O
LPS-induced	O	ADJ	B
TNF	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
augmenting	O	VERB	O
both	O	CCONJ	O
transcription	O	NOUN	B
and	O	CCONJ	O
MRNA	O	NOUN	B
stability	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
tumour	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
induction	O	NOUN	B
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
,	O	PUNCT	O
experiments	O	NOUN	B
were	O	AUX	O
designed	O	VERB	O
to	O	PART	O
analyse	O	VERB	B
in	O	ADP	O
detail	O	NOUN	O
the	O	DET	O
priming	O	NOUN	B
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
LPS	O	NOUN	B
response	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


IFN-gamma	B-protein	NOUN	B
pre-treatment	O	NOUN	B
affected	O	VERB	B
the	O	DET	O
magnitude	O	NOUN	B
rather	O	ADV	O
than	O	ADP	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LPS	O	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
transcriptional	O	ADJ	B
rate	O	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
using	O	VERB	O
a	O	DET	O
consensus	B-DNA	NOUN	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
oligonucleotide	I-DNA	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
increased	O	VERB	B
mRNA	B-RNA	NOUN	B
stability	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
duration	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
accumulation	O	NOUN	B
was	O	AUX	O
longer	O	ADJ	O
following	O	VERB	O
LPS	O	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
primed	O	VERB	B
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
being	O	AUX	O
of	O	ADP	O
greater	O	ADJ	O
magnitude	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
biochemical	O	ADJ	B
and	O	CCONJ	O
mutagenesis	O	NOUN	B
analyses	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
multiple	O	ADJ	B
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
these	O	DET	O
independent	O	ADJ	O
sites	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
initiator-like	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
present	O	ADJ	O
at	O	ADP	O
the	O	DET	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
Ets	B-DNA	NOUN	B
consensus	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
full	O	ADJ	O
promoter	B-DNA	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
believe	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MAZ	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
likely	O	ADJ	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
developmental	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	B-protein	NOUN	B
products	I-protein	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
contain	O	VERB	O
the	O	DET	O
basic-helix-loop-helix	B-protein	ADJ	B
motif	I-protein	NOUN	I
characteristic	O	ADJ	I
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
family	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
canonical	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
CANNTG	I-DNA	NOUN	I
as	O	ADP	O
protein	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
Epo	B-protein	NOUN	B
acts	O	VERB	O
at	O	ADP	O
both	O	CCONJ	O
transcriptional	O	ADJ	B
and	O	CCONJ	O
posttranscriptional	O	ADJ	B
levels	O	NOUN	O
on	O	ADP	O
the	O	DET	O
TAL1	B-protein	NOUN	B
locus	O	NOUN	B
in	O	ADP	O
Friend	B-cell_line	NOUN	B
virus-induced	I-cell_line	ADJ	I
erythroblasts	I-cell_line	NOUN	I
and	O	CCONJ	O
establish	O	VERB	O
a	O	DET	O
link	O	NOUN	O
between	O	ADP	O
Epo	B-protein	NOUN	B
signaling	O	NOUN	O
mechanisms	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
diverse	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
lineages	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
technique	O	NOUN	B
was	O	AUX	O
successfully	O	ADV	O
applied	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
differences	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
potent	O	ADJ	O
differentiation	O	NOUN	B
inducers	O	NOUN	B
:	O	PUNCT	O
12-O-tetradecanoylphorbol	O	NOUN	O
13-acetate	O	NOUN	O
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D2	O	NOUN	I
(	O	PUNCT	O
VD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
purely	O	ADV	O
enhancer-dependent	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
such	O	ADJ	O
as	O	ADP	O
TNF	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	O
region	I-DNA	NOUN	O
(	O	PUNCT	O
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
okadaic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
OKA	O	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
HIV	O	NOUN	B
transcription	O	NOUN	O
through	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
enhancer	O	NOUN	B
,	O	PUNCT	O
responding	O	VERB	B
to	O	PART	O
the	O	DET	O
factor	O	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
promoter	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
.	O	PUNCT	O


Responsiveness	O	NOUN	B
of	O	ADP	O
LTR	B-DNA	NOUN	B
constructs	I-DNA	NOUN	B
deleted	O	VERB	O
of	O	ADP	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
to	O	PART	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
upon	O	SCONJ	O
OKA	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
TNF	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
SP1	B-protein	NOUN	B
phosphorylation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
OKA	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
selective	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
serine-threonine	B-protein	ADJ	B
phosphatase	I-protein	NOUN	I
PP2A	B-protein	NOUN	B
,	O	PUNCT	O
facilitates	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transcription	B-protein	NOUN	B
complex	I-protein	NOUN	I
involving	O	VERB	O
general	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
bases	O	NOUN	I
for	O	ADP	O
cytokine	O	NOUN	B
redundancy	O	NOUN	B
and	O	CCONJ	O
pleiotropy	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBLs	B-cell_type	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
cytokines	B-protein	NOUN	B
with	O	ADP	O
shared	O	VERB	B
and	O	CCONJ	O
distinct	O	ADJ	O
actions	O	NOUN	B
.	O	PUNCT	O


IL-7	B-protein	NOUN	B
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
induced	O	VERB	B
the	O	DET	O
same	O	ADJ	O
complexes	O	NOUN	B
as	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
feature	O	NOUN	O
explained	O	VERB	O
by	O	ADP	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
similar	O	ADJ	O
tyrosine-phosphorylated	B-protein	ADJ	B
motifs	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	B
and	O	CCONJ	O
IL-7R	B-protein	NOUN	B
that	O	PRON	O
can	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
docking	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
single	O	ADJ	O
cytokine	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
different	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
under	O	ADP	O
different	O	ADJ	O
physiological	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
indicate	O	VERB	O
two	O	NUM	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
distinct	O	ADJ	O
cytokines	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
the	O	DET	O
same	O	ADJ	O
Stat	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Various	O	ADJ	O
stimuli	O	NOUN	B
,	O	PUNCT	O
typically	O	ADV	O
those	O	DET	O
associated	O	VERB	B
with	O	ADP	I
stress	O	NOUN	B
or	O	CCONJ	O
pathogens	O	NOUN	B
,	O	PUNCT	O
rapidly	O	ADV	O
inactivate	O	VERB	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
either	O	CCONJ	O
serine-32	O	NOUN	B
or	O	CCONJ	O
serine-36	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	O
was	O	AUX	O
mutated	O	VERB	B
,	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
did	O	AUX	O
not	O	PART	O
undergo	O	VERB	O
signal-induced	O	ADJ	B
phosphorylation	O	NOUN	B
or	O	CCONJ	O
degradation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
activated	O	VERB	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
erythropoietin	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
by	O	ADP	O
proteins	O	NOUN	B
binding	O	VERB	I
to	O	PART	O
GATA-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
motifs	I-DNA	NOUN	B
.	O	PUNCT	O


Erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
Epo	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
primary	O	ADJ	B
regulator	O	NOUN	I
of	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
acts	O	VERB	O
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
a	O	DET	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
EpoR	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
erythroid	B-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
150	B-DNA	NUM	O
bp	I-DNA	NOUN	O
hEpoR	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
exhibited	O	VERB	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	O
activity	O	NOUN	B
in	O	ADP	O
erythroid	O	ADJ	B
OCIM1	B-cell_line	NOUN	I
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
reflecting	O	VERB	O
the	O	DET	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
hEpoR	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GATA-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
this	O	DET	O
promoter	O	NOUN	B
lacking	O	VERB	O
a	O	DET	O
TATA	B-DNA	NOUN	B
sequence	I-DNA	NOUN	O
were	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
a	O	DET	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
increasing	O	VERB	O
GATA-1	B-protein	NOUN	B
levels	O	NOUN	B
via	O	ADP	O
co-transfection	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transactivate	O	VERB	B
the	O	DET	O
hEpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
non-erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
highly	O	ADV	O
active	O	ADJ	O
OCIM1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
GATA-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
comparable	O	ADJ	O
in	O	ADP	O
OCIM1	B-cell_line	NOUN	B
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
while	O	SCONJ	O
GATA-1	B-protein	NOUN	B
can	O	AUX	O
transactivate	O	VERB	B
the	O	DET	O
EpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
hEpoR	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
does	O	AUX	O
not	O	PART	O
depend	O	VERB	O
on	O	ADP	O
GATA-1	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
proteins	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
these	O	DET	O
two	O	NUM	O
latter	O	ADJ	O
genes	O	NOUN	B
is	O	AUX	O
approximately	O	ADV	O
65	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
includes	O	VERB	O
domains	O	NOUN	B
and	O	CCONJ	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
(	O	PUNCT	O
the	O	DET	O
leucine	B-protein	NOUN	B
zipper-like	I-protein	ADJ	B
and	O	CCONJ	O
the	O	DET	O
RGD	B-protein	NOUN	B
domain	I-protein	NOUN	O
,	O	PUNCT	O
a	O	DET	O
serine	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
histidine	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NH2-	B-protein	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
COOH-terminal	B-protein	ADJ	B
portion	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
postulated	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
nm23	B-protein	NOUN	B
function	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
interferon-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	B
sequence	I-DNA	NOUN	O
mediates	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IgG	B-DNA	NOUN	B
Fc	I-DNA	NOUN	B
receptor	I-DNA	NOUN	I
type	I-DNA	NOUN	I
IC	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
by	O	ADP	O
interferon-gamma	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RI	I-protein	NOUN	I
transcript	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
monoblast-like	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
elevated	O	ADJ	B
within	O	ADP	O
3	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
peaked	O	VERB	O
12	O	NUM	O
hr	O	NOUN	O
after	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Double-stranded	B-DNA	ADJ	B
GIRE	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
a	O	DET	O
scrambled	B-DNA	VERB	B
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
specifically	O	ADV	O
bound	O	VERB	O
by	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
from	O	ADP	O
IFN-gamma	B-cell_line	NOUN	B
treated	I-cell_line	ADJ	B
U937	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RIC	I-DNA	NOUN	I
GIRE	I-DNA	NOUN	B
is	O	AUX	O
homologous	O	ADJ	O
to	O	PART	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
GAS	B-DNA	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
guanylate	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
and	O	CCONJ	O
to	O	PART	O
X	B-DNA	NOUN	O
box	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
MHC	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Constitutively	O	ADV	B
activated	O	VERB	B
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathway	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
transformed	O	VERB	O
with	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
Jak	B-protein	NOUN	B
kinases	I-protein	NOUN	I
Jak1	B-protein	NOUN	I
and	O	CCONJ	O
Jak3	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
signal	O	NOUN	B
transducer	O	NOUN	I
and	O	CCONJ	O
activator	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
proteins	I-protein	NOUN	I
Stat3	B-protein	NOUN	B
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
are	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
this	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
was	O	AUX	O
constitutively	O	ADV	B
activated	O	VERB	B
in	O	ADP	O
HTLV-I-transformed	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
HTLV-I-infected	B-cell_line	ADJ	B
cord	I-cell_line	NOUN	I
blood	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
transition	O	NOUN	B
from	O	ADP	O
IL-2	B-protein	NOUN	B
-dependent	O	ADJ	O
to	O	PART	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
growth	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
acquisition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
activated	O	VERB	B
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathway	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
pathway	O	NOUN	B
participates	O	VERB	O
in	O	ADP	O
HTLV-I-mediated	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
transformation	O	NOUN	O
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide	O	NOUN	I
decreases	O	VERB	B
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
endothelial	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
NO	O	NOUN	B
inhibited	O	VERB	B
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
alpha-stimulated	O	ADJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
35-55	O	NUM	O
%	O	NOUN	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
surface	O	NOUN	I
enzyme	O	NOUN	B
immunoassays	O	NOUN	I
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


NO	O	NOUN	B
also	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
endothelial	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
leukocyte	B-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
(	O	PUNCT	O
E-selectin	B-protein	NOUN	B
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
lesser	O	ADJ	B
extent	O	NOUN	B
,	O	PUNCT	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
secretable	O	ADJ	B
cytokines	B-protein	NOUN	I
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
IL-8	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Nuclear	O	ADJ	B
run-on	O	ADJ	I
assays	O	NOUN	I
,	O	PUNCT	O
transfection	O	NOUN	B
studies	O	NOUN	I
using	O	VERB	O
various	O	ADJ	O
VCAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
represses	O	VERB	B
VCAM-1	B-protein	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
inhibiting	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Secreted	O	VERB	B
from	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
bone	O	NOUN	B
marrow-derived	B-protein	ADJ	I
MIP-1	I-protein	NOUN	O
alpha/GOS19	I-protein	DET	O
inhibits	O	VERB	B
primitive	B-cell_type	ADJ	O
hematopoietic	I-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
homeostatic	O	ADJ	B
control	O	NOUN	I
of	O	ADP	I
stem	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
also	O	ADV	O
induces	O	VERB	B
chemotaxis	O	NOUN	B
and	O	CCONJ	O
inflammatory	O	ADJ	B
responses	O	NOUN	I
in	O	ADP	O
mature	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
mechanisms	O	NOUN	B
which	O	DET	O
control	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
MIP-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
/GOS19	B-protein	NOUN	O
.	O	PUNCT	O


Previous	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
widely	O	ADV	O
expressed	O	VERB	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
the	O	DET	O
ICK-1	B-protein	NOUN	B
family	I-protein	NOUN	O
)	O	PUNCT	O
affect	O	VERB	O
the	O	DET	O
GOS19	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
communication	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
pathway	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
macrophage	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U937	B-cell_line	NOUN	O
is	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
that	O	DET	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MNP	B-DNA	NOUN	B
site	I-DNA	NOUN	B
which	O	DET	O
does	O	AUX	O
not	O	PART	O
abrogate	O	VERB	O
ICK-1	O	NOUN	B
binding	O	NOUN	B
inactivates	O	VERB	B
the	O	DET	O
GOS19.1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
reduces	O	VERB	B
its	O	PRON	O
activity	O	NOUN	B
by	O	ADP	O
fourfold	O	ADV	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MNP	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
binding	O	NOUN	B
at	O	ADP	O
the	O	DET	O
MNP	B-DNA	NOUN	B
site	I-DNA	NOUN	B
constitutes	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Toremifene	O	NOUN	B
exerts	O	VERB	O
multiple	O	ADJ	B
and	O	CCONJ	O
varied	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	O
mononuclear	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
also	O	ADV	O
stimulates	O	VERB	B
GTP	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


Jak2	B-protein	NOUN	B
kinase	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
phosphorylate	O	VERB	B
STAT	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
IL-5	B-protein	NOUN	B
induces	O	VERB	B
two	O	NUM	O
GAS-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
is	O	AUX	O
STAT1	B-protein	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
transcriptional	B-protein	ADJ	B
activator	I-protein	NOUN	I
of	O	ADP	O
many	O	ADJ	O
viral	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
cellular	I-DNA	ADJ	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
unlike	O	ADP	O
another	O	DET	O
tumor	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
p53	B-protein	NOUN	B
,	O	PUNCT	O
Rb	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
have	O	AUX	O
any	O	DET	O
significant	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
basal	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
specifically	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
IE2	B-protein	NOUN	B
rather	O	ADV	O
than	O	ADP	O
other	O	ADJ	O
cellular	B-protein	ADJ	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
general	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
may	O	AUX	O
regulate	O	VERB	B
the	O	DET	O
life	O	NOUN	B
cycle	O	NOUN	I
of	O	ADP	O
HCMV	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
endemic	O	ADJ	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
marker	O	NOUN	B
for	O	ADP	O
metastatic	O	ADJ	B
potential	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancer	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
assessed	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
9	O	NUM	O
keratoacanthomas	O	NOUN	B
(	O	PUNCT	O
KAs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
26	O	NUM	O
squamous	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
SCCs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
25	O	NUM	O
basal	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
BCCs	O	NOUN	B
)	O	PUNCT	O
using	O	VERB	O
immunohistochemistry	O	NOUN	B
.	O	PUNCT	O


And	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
between	O	ADP	O
SCC	O	NOUN	B
with	O	ADP	O
metastasis	O	NOUN	B
and	O	CCONJ	O
SCC	O	NOUN	B
without	O	ADP	O
metastasis	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
contradict	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
concerning	O	VERB	O
the	O	DET	O
possible	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
nm23	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
as	O	ADP	O
a	O	DET	O
metastatic	O	ADJ	B
suppressor	O	NOUN	I
gene	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancer	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
major	B-DNA	ADJ	B
histocompatibility	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
MHC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
class	I-DNA	NOUN	B
II	I-DNA	NUM	I
genes	I-DNA	NOUN	I
encode	O	VERB	B
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
proteins	I-protein	NOUN	O
that	O	PRON	O
bind	O	VERB	B
antigenic	O	ADJ	B
peptide	O	NOUN	I
for	O	ADP	O
presentation	O	NOUN	B
to	O	PART	O
T-cells	B-cell_type	NOUN	B
.	O	PUNCT	O


RB-defective	B-cell_line	ADJ	B
tumor	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
are	O	AUX	O
non-inducible	O	ADJ	B
for	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
very	O	ADV	O
weakly	O	ADV	O
inducible	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
transfection	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
different	O	ADJ	O
lines	O	NOUN	B
with	O	ADP	O
RB	B-DNA	NOUN	B
expression	I-DNA	NOUN	O
vectors	I-DNA	NOUN	O
re-establishes	O	VERB	B
or	O	CCONJ	O
substantially	O	ADV	O
enhances	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
inducibility	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
matrix-bound	O	ADJ	I
RB	B-protein	NOUN	I
was	O	AUX	O
detectable	O	ADJ	B
in	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
loss	O	NOUN	B
of	O	ADP	O
RB	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
responsible	O	ADJ	O
for	O	ADP	O
decreased	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
in	O	ADP	O
these	O	DET	O
lines	O	NOUN	B
.	O	PUNCT	O


CIITA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
normally	O	ADV	O
inducible	O	ADJ	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
non-inducible	I-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
RB-defective	I-cell_line	ADJ	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
one	O	NUM	O
line	O	NOUN	O
,	O	PUNCT	O
re-expression	O	NOUN	B
of	O	ADP	O
RB	B-protein	NOUN	B
has	O	AUX	O
no	O	DET	O
effect	O	NOUN	O
on	O	ADP	O
CIITA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induction	O	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
12	I-protein	NUM	I
induces	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT4	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
known	O	VERB	O
as	O	ADP	O
STATs	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
tyrosine	O	NOUN	B
phosphorylated	O	ADJ	B
and	O	CCONJ	O
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
hematopoietin	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
activate	O	VERB	B
JAK	B-protein	NOUN	B
kinases	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
IL-12	B-protein	NOUN	B
stimulates	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
complex	I-protein	NOUN	I
that	O	PRON	O
recognizes	O	VERB	O
a	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
previously	O	ADV	O
shown	O	VERB	O
to	O	PART	O
bind	O	VERB	B
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
complex	O	NOUN	B
contains	O	VERB	O
STAT4	B-protein	NOUN	B
.	O	PUNCT	O


Temperature-induced	O	ADJ	B
down-regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
leucocyte	I-cell_type	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
adaptive	O	ADJ	B
mechanisms	O	NOUN	I
which	O	DET	O
occur	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
in	O	ADP	O
glucocorticoid	O	NOUN	B
target	O	NOUN	B
tissues	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Hypercortisolaemia	O	NOUN	B
,	O	PUNCT	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
decreased	O	VERB	B
affinity	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
decreased	O	VERB	B
binding	O	NOUN	B
capacity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
weak	O	ADJ	B
but	O	CCONJ	O
significant	O	ADJ	O
negative	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
body	O	NOUN	B
temperature	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
There	O	PRON	O
is	O	AUX	O
no	O	DET	O
obvious	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
by	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
concentrations	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
cytoplasmic	B-protein	ADJ	B
tyrosine	I-protein	NOUN	B
kinases	I-protein	NOUN	I
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
aspect	O	NOUN	O
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
integrins	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
integrin	B-protein	NOUN	B
ligation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
subunits	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
driven	O	VERB	O
by	O	ADP	O
a	O	DET	O
promoter	B-DNA	NOUN	B
containing	O	VERB	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
mRNAs	B-RNA	NOUN	B
for	O	ADP	O
immediate-early	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
cytokine	B-protein	NOUN	B
interleukin	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
beta	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
adhering	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
pre-treatment	O	NOUN	B
with	O	ADP	O
cytochalasin	O	NOUN	B
D	O	NOUN	I
suppresses	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
FAK	B-protein	NOUN	B
and	O	CCONJ	O
paxillin	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
Syk	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
message	O	NOUN	O
induction	O	NOUN	B
is	O	AUX	O
unaffected	O	ADJ	O
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
New	O	ADJ	B
World	O	NOUN	I
primates	O	NOUN	I
express	O	VERB	O
an	O	DET	O
inhibitor	O	NOUN	B
that	O	PRON	O
influences	O	VERB	B
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
binding	O	NOUN	B
characteristics	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
dexamethasone	O	NOUN	B
binding	O	NOUN	B
in	O	ADP	O
cytosol	O	NOUN	B
prepared	O	VERB	O
from	O	ADP	O
B95-8	B-cell_line	NOUN	B
lymphoid	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
cotton	O	NOUN	B
top	O	NOUN	O
tamarin	O	NOUN	O
(	O	PUNCT	O
Saguinus	O	X	B
oedipus	O	X	I
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
cytosol	O	NOUN	B
prepared	O	VERB	O
from	O	ADP	O
human	O	ADJ	B
or	O	CCONJ	O
rat	O	NOUN	B
tissues	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	O
was	O	AUX	O
heat	O	NOUN	B
labile	O	ADJ	I
and	O	CCONJ	O
trypsin	B-protein	NOUN	B
sensitive	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
B95-8	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
contain	O	VERB	O
a	O	DET	O
competitive	O	ADJ	B
inhibitor	O	NOUN	B
that	O	PRON	O
prevents	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
to	O	PART	O
its	O	PRON	O
cognate	B-protein	ADJ	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Duffy	B-DNA	NOUN	B
antigen/chemokine	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
DARC	B-DNA	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
a	O	DET	O
single	O	ADJ	O
exon	B-DNA	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
most	O	ADJ	O
Duffy-negative	O	ADJ	B
blacks	O	NOUN	I
carry	O	VERB	O
a	O	DET	O
silent	B-DNA	ADJ	B
FY*B	I-DNA	NOUN	B
allele	I-DNA	NOUN	O
with	O	ADP	O
a	O	DET	O
single	O	ADJ	O
T	O	NOUN	O
to	O	PART	O
C	O	NOUN	O
substitution	O	NOUN	B
at	O	ADP	O
nucleotide	O	NOUN	B
-46	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
pokeweed	B-protein	NOUN	B
mitogen	I-protein	NOUN	I
(	O	PUNCT	O
PWM	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
early	B-DNA	ADJ	B
growth	I-DNA	NOUN	O
response-1	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
(	O	PUNCT	O
EGR-1	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
assays	O	NOUN	O
with	O	ADP	O
EGR-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
fragments	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
demonstrated	O	VERB	O
that	O	SCONJ	O
PWM	B-protein	NOUN	B
induced	O	ADJ	B
EGR-1	B-DNA	NOUN	B
transcription	O	NOUN	B
is	O	AUX	O
conferred	O	VERB	O
by	O	ADP	O
the	O	DET	O
CArG	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
(	O	PUNCT	O
C	B-DNA	NOUN	O
C	I-DNA	NOUN	O
[	I-DNA	PUNCT	O
AT	I-DNA	NOUN	O
]	I-DNA	PUNCT	O
6GG	I-DNA	ADJ	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
EGR-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
conserved	B-DNA	VERB	O
motif	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
expressed	O	VERB	B
by	O	ADP	O
human	B-cell_line	ADJ	B
Th2-type	I-cell_line	ADJ	B
lymphocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
core	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
CTTGG	O	NOUN	B
...	O	PUNCT	O
CCAAG	O	NOUN	B
which	O	DET	O
is	O	AUX	O
present	O	ADJ	O
as	O	ADP	O
part	O	NOUN	O
of	O	ADP	O
larger	O	ADJ	B
palindromic	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
each	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
suggest	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
may	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
a	O	DET	O
new	O	ADJ	O
family	O	NOUN	B
of	O	ADP	O
trans-acting	B-protein	ADJ	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Considering	O	VERB	O
the	O	DET	O
strong	O	ADJ	O
positive	O	ADJ	B
regulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
this	O	DET	O
element	B-DNA	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
presence	O	NOUN	B
in	O	ADP	O
several	O	ADJ	O
T-cell-expressed	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
may	O	AUX	O
be	O	AUX	O
crucial	O	ADJ	O
to	O	PART	O
the	O	DET	O
coordinated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cytokines	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
helper	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


A	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
PEER	B-cell_line	NOUN	B
,	O	PUNCT	O
dies	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
gene	B-DNA	NOUN	B
,	O	PUNCT	O
TINUR	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
cloned	O	VERB	B
from	O	ADP	O
apoptotic	B-cell_line	ADJ	B
PEER	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


TINUR	B-DNA	NOUN	B
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
NGFI-B/nur77	B-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
an	O	DET	O
orphan	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
by	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	I
TNF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
mobilization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	B-protein	ADJ	I
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Since	O	SCONJ	O
salicylates	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
preventing	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
inhibitor	O	NOUN	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
a	O	DET	O
potential	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
this	O	DET	O
pathway	O	NOUN	B
by	O	ADP	O
acetylsalicylate	O	NOUN	B
(	O	PUNCT	O
aspirin	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
human	B-cell_line	ADJ	B
umbilical	I-cell_line	ADJ	I
vein	I-cell_line	NOUN	I
endothelial	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
HUVECs	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
surface	O	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
TNF	B-protein	NOUN	B
was	O	AUX	O
dose-dependently	O	ADV	O
reduced	O	VERB	B
by	O	ADP	O
aspirin	O	NOUN	B
over	O	ADP	O
the	O	DET	O
same	O	ADJ	O
range	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
hardly	O	ADV	O
affected	O	VERB	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
phosphatase	B-protein	NOUN	B
inhibitors	O	NOUN	I
involves	O	VERB	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
at	O	ADP	O
phosphatase	B-protein	NOUN	B
2A-sensitive	I-protein	ADJ	I
sites	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
serine/threonine	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
phosphorylation	O	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


Our	O	PRON	O
studies	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
incubation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
with	O	ADP	O
low	O	ADJ	B
concentrations	O	NOUN	B
(	O	PUNCT	O
approximately	O	ADV	O
1-5	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
calyculin	O	NOUN	B
A	O	NOUN	I
or	O	CCONJ	O
okadaic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
potent	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
type	I-protein	NOUN	I
1	I-protein	NUM	I
(	I-protein	PUNCT	O
PP-1	I-protein	NOUN	B
)	I-protein	PUNCT	O
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
2A	I-protein	NOUN	I
(	O	PUNCT	O
PP-2A	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
induces	O	VERB	B
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
even	O	ADV	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
any	O	DET	O
cellular	O	ADJ	B
stimulus	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
phosphorylated	B-protein	ADJ	B
I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
from	O	ADP	O
calyculin	B-cell_line	NOUN	B
A-treated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
that	O	DET	O
from	O	ADP	O
TNF-alpha-stimulated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
sensitive	O	ADJ	B
to	O	PART	O
PP-2A	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
fundamental	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
two	O	NUM	O
different	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inducers	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
mediated	O	VERB	O
through	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
TNF-alpha	B-protein	NOUN	B
-inducible	O	ADJ	O
and	O	CCONJ	O
the	O	DET	O
PP-2A-opposing	B-protein	ADJ	B
kinases	I-protein	NOUN	I
,	O	PUNCT	O
may	O	AUX	O
serve	O	VERB	O
to	O	PART	O
target	O	VERB	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
for	O	ADP	O
proteasome	B-protein	NOUN	B
-mediated	O	ADJ	O
degradation	O	NOUN	B
.	O	PUNCT	O


Sp1	B-protein	NOUN	B
functions	O	VERB	B
in	O	ADP	O
a	O	DET	O
chromatin	B-DNA	NOUN	B
-dependent	O	ADJ	O
manner	O	NOUN	O
to	O	PART	O
augment	O	VERB	O
human	B-DNA	ADJ	B
alpha-globin	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
this	O	DET	O
G	B-DNA	NOUN	B
+	I-DNA	CCONJ	O
C-rich	I-DNA	ADJ	B
region	I-DNA	NOUN	I
in	O	ADP	O
augmenting	O	VERB	O
alpha-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
far-upstream	B-DNA	ADJ	B
alpha-globin	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
,	O	PUNCT	O
HS-40	B-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
alpha-globin	B-DNA	NOUN	B
G	I-DNA	NOUN	I
+	I-DNA	CCONJ	O
C-rich	I-DNA	ADJ	B
5	I-DNA	NUM	I
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
augments	O	VERB	O
alpha-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
a	O	DET	O
chromatin	B-DNA	NOUN	B
-dependent	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
earlier	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
with	O	ADP	O
SEA	O	NOUN	B
presented	O	VERB	O
on	O	ADP	O
Chinese	B-cell_line	ADJ	B
hamster	I-cell_line	NOUN	I
ovary	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
CHO	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-DR	I-cell_line	NOUN	O
transfectants	I-cell_line	NOUN	B
coexpressing	O	VERB	B
either	O	CCONJ	O
B7	B-protein	NOUN	B
or	O	CCONJ	O
LFA-3	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
distinct	O	ADJ	O
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
.	O	PUNCT	O


LFA-3	B-protein	NOUN	B
induced	O	VERB	B
moderate	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
influence	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
B7	B-protein	NOUN	B
costimulation	O	NOUN	B
strongly	O	ADV	O
induced	O	VERB	B
both	O	CCONJ	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
substantially	O	ADV	O
enhanced	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
CHO-DR/B7/LFA-3	B-cell_line	NOUN	O
triple	I-cell_line	ADJ	B
transfectant	I-cell_line	NOUN	I
induced	O	VERB	B
a	O	DET	O
further	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	B-protein	NOUN	I
proteins	I-protein	NOUN	I
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
double	B-cell_line	ADJ	O
transfectants	I-cell_line	NOUN	B
.	O	PUNCT	O


The	O	DET	O
AP-1	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
contained	O	VERB	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
Jun-D	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Fra-1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
marginal	O	ADJ	B
amounts	O	NOUN	O
of	O	ADP	O
Jun-B	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
recognizes	O	VERB	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
BSAP	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
dioxin-mediated	O	ADJ	O
alteration	O	NOUN	B
of	O	ADP	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
gel	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
complex	I-protein	NOUN	I
in	O	ADP	O
IM-9	O	NOUN	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
that	O	PRON	O
by	O	ADP	O
several	O	ADJ	O
criteria	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
AhR	B-protein	NOUN	B
could	O	AUX	O
interfere	O	VERB	O
with	O	ADP	O
BSAP	B-protein	NOUN	B
-stimulated	O	ADJ	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	B
by	O	ADP	O
competition	O	NOUN	B
for	O	ADP	O
a	O	DET	O
common	O	ADJ	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
identified	O	VERB	B
a	O	DET	O
differentiation	B-protein	NOUN	B
inhibitory	I-protein	ADJ	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
I-factor	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
mouse	B-cell_line	NOUN	B
myeloid	I-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	I
M1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADP	O
a	O	DET	O
murine	B-protein	ADJ	B
homolog	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
nm23-H2	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
experiment	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
nm23	B-protein	NOUN	B
proteins	I-protein	NOUN	I
on	O	ADP	O
various	O	ADJ	O
differentiation	O	NOUN	B
induction	O	NOUN	B
systems	O	NOUN	O
of	O	ADP	O
human	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
including	O	VERB	O
HL-60	B-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
U937	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
HEL/S	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
KU812F	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
K562	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
and	I-cell_line	CCONJ	O
HEL	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
recombinant	B-protein	ADJ	B
human	I-protein	ADJ	B
nm23-H1	I-protein	NOUN	B
,	I-protein	PUNCT	O
-H2	I-protein	NOUN	B
,	I-protein	PUNCT	O
mouse	I-protein	NOUN	B
nm23-M1	I-protein	NOUN	B
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
-M2	I-protein	NOUN	O
proteins	I-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
the	O	DET	O
differentiation	O	NOUN	B
inhibitory	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
I-factor/nm23	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
restricted	O	ADJ	O
to	O	PART	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
M1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
the	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	I
is	O	AUX	O
exhibited	O	VERB	O
without	O	ADP	O
species	O	NOUN	B
specificity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
the	O	DET	O
differentiation	O	NOUN	B
inhibitory	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
the	O	DET	O
nm23/NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
protein	I-protein	NOUN	I
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
its	O	PRON	O
enzyme	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
requires	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
N-terminal	O	ADJ	B
peptides	O	NOUN	I
.	O	PUNCT	O


Lipopolysaccharide-induced	O	ADJ	B
E-selectin	B-protein	NOUN	B
expression	O	NOUN	B
requires	O	VERB	O
continuous	O	ADJ	B
presence	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
bactericidal/permeability-increasing	B-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
by	O	ADP	O
LPS	O	NOUN	B
express	O	VERB	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
mediating	O	VERB	O
neutrophil	B-cell_type	NOUN	B
adhesion	O	NOUN	B
during	O	ADP	O
inflammation	O	NOUN	B
.	O	PUNCT	O


rBPI21	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
recombinant	B-protein	ADJ	B
N-terminal	I-protein	ADJ	O
fragment	I-protein	NOUN	O
of	O	ADP	O
human	B-protein	ADJ	B
bactericidal/permeability-increasing	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
BPI	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inhibited	O	VERB	B
LPS-induced	O	ADJ	B
E-selectin	B-protein	NOUN	B
expression	O	NOUN	B
when	O	SCONJ	O
added	O	VERB	O
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
time	O	NOUN	O
as	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
up	O	ADP	O
to	O	PART	O
6	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
,	O	PUNCT	O
LPS	O	NOUN	B
.	O	PUNCT	O


GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
share	O	VERB	O
common	O	ADJ	O
control	O	NOUN	B
mechanisms	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
costimulatory	O	ADJ	B
signals	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
also	O	ADV	O
required	O	VERB	O
both	O	CCONJ	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
costimulatory	O	ADJ	B
signals	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
promoter	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
enhancer	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
are	O	AUX	O
mainly	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Human	O	ADJ	B
T	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
infects	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
lead	O	VERB	O
to	O	PART	O
increase	O	VERB	B
GM-CSF	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
HTLV-1	B-protein	NOUN	B
transactivator	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
tax	B-protein	NOUN	O
,	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
costimulatory	O	ADJ	B
signal	O	NOUN	I
for	O	ADP	O
GM-CSF	O	NOUN	B
and	O	CCONJ	O
IL-2	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
cooperate	O	VERB	O
with	O	ADP	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
to	O	PART	O
mediate	O	VERB	O
high	O	ADJ	O
level	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Tax	O	NOUN	B
activates	O	VERB	B
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
through	O	ADP	O
the	O	DET	O
CK-1	B-DNA	NOUN	B
/CD28RE	B-DNA	NOUN	O
region	O	NOUN	O
and	O	CCONJ	O
also	O	ADV	O
activates	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
binding	O	NOUN	I
to	O	PART	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


3.	O	X	O
Danazol	O	NOUN	B
decreased	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
rate	O	NOUN	I
of	O	ADP	O
ER	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
to	O	PART	O
approximately	O	ADV	O
50	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
in	O	ADP	O
a	O	DET	O
run-on	O	ADJ	B
assay	O	NOUN	I
.	O	PUNCT	O


4.	O	X	O
Danazol	O	NOUN	B
may	O	AUX	O
release	O	VERB	O
estrogen	O	NOUN	B
predominance	O	NOUN	B
via	O	ADP	O
the	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
for	O	ADP	O
ER	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
ER	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
ER	B-protein	NOUN	B
expressions	O	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
-mediated	O	ADJ	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
early	O	ADJ	O
event	O	NOUN	O
in	O	ADP	O
the	O	DET	O
inflammatory	O	ADJ	B
process	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
compounds	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
mixed	O	ADJ	O
lymphocyte	O	NOUN	O
reaction	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
inhibition	O	NOUN	B
was	O	AUX	O
reversed	O	VERB	O
by	O	ADP	O
exogenous	O	ADJ	B
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
calcium-independent	B-protein	ADJ	B
anti-CD28	I-protein	ADJ	B
Ab	I-protein	NOUN	I
and	O	CCONJ	O
PMA-induced	O	ADJ	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
was	O	AUX	O
resistant	O	ADJ	B
.	O	PUNCT	O


By	O	ADP	O
these	O	DET	O
functional	O	ADJ	B
criteria	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
believe	O	VERB	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
two	O	NUM	O
structurally	O	ADV	B
distinct	O	ADJ	O
,	O	PUNCT	O
novel	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
-1-mediated	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
examined	O	VERB	O
mRNA	B-RNA	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
various	O	ADJ	O
V-ATPase	B-protein	NOUN	B
subunits	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
native	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
THP-1	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
transcriptional	O	ADJ	B
and	O	CCONJ	O
post-transcriptional	O	ADJ	B
mechanisms	O	NOUN	B
could	O	AUX	O
account	O	VERB	O
for	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
V-ATPase	B-protein	NOUN	I
content	O	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
nuclear	O	ADJ	B
runoff	O	ADJ	I
experiments	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
subunit	O	NOUN	B
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
B2	B-protein	NOUN	B
isoform	I-protein	NOUN	I
(	O	PUNCT	O
Mr	O	NOUN	O
=	O	ADJ	O
56	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
amplified	O	VERB	B
primarily	O	ADV	O
by	O	ADP	O
transcriptional	O	ADJ	B
means	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
begun	O	VERB	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B2	B-DNA	NOUN	B
subunit	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	B
and	O	CCONJ	O
ribonuclease	B-protein	NOUN	B
protection	O	NOUN	O
analyses	O	NOUN	O
indicate	O	VERB	O
a	O	DET	O
single	O	ADJ	O
major	B-DNA	ADJ	O
transcriptional	I-DNA	ADJ	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
.	O	PUNCT	O


Synergy	O	NOUN	B
between	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	O
pathways	O	NOUN	O
is	O	AUX	O
obligatory	O	ADJ	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
in	O	ADP	O
B	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
:	O	PUNCT	O
implication	O	NOUN	B
for	O	ADP	O
c-fos	B-DNA	NOUN	B
control	O	NOUN	I
via	O	ADP	O
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	B
and	O	CCONJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Kinase	B-protein	NOUN	B
C	I-protein	NOUN	I
mediates	O	VERB	O
its	O	PRON	O
effects	O	NOUN	B
via	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
serum	B-protein	NOUN	B
response	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
SRF	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
serum	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
SRE	B-DNA	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
cAMP	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
mediate	O	VERB	O
their	O	PRON	O
effects	O	NOUN	B
via	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
CREB	B-protein	NOUN	B
(	O	PUNCT	O
cAMP	B-protein	NOUN	B
regulatory	I-protein	ADJ	O
element	I-protein	NOUN	O
binding	I-protein	NOUN	O
protein	I-protein	NOUN	O
)	O	PUNCT	O
presumably	O	ADV	O
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
or	O	CCONJ	O
calmodulin-regulated	B-protein	ADJ	B
kinase	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
any	O	DET	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
pathways	O	NOUN	B
alone	O	ADV	O
has	O	AUX	O
little	O	ADJ	O
or	O	CCONJ	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
c-fos	B-DNA	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
synergy	O	NOUN	B
between	O	ADP	O
the	O	DET	O
kinase	B-protein	NOUN	B
C	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
is	O	AUX	O
needed	O	VERB	O
for	O	ADP	O
efficient	O	ADJ	B
c-fos	B-DNA	NOUN	B
induction	O	NOUN	I
since	O	SCONJ	O
neither	O	DET	O
of	O	ADP	O
these	O	DET	O
two	O	NUM	O
alone	O	ADV	O
induces	O	VERB	O
c-fos	B-DNA	NOUN	B
well	O	ADV	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
cell-specific	O	ADJ	B
patterns	O	NOUN	I
of	O	ADP	O
synergy	O	NOUN	B
are	O	AUX	O
an	O	DET	O
essential	O	ADJ	O
feature	O	NOUN	O
for	O	ADP	O
c-fos	B-DNA	NOUN	B
induction	O	NOUN	I
and	O	CCONJ	O
may	O	AUX	O
be	O	AUX	O
relevant	O	ADJ	B
for	O	ADP	O
c-fos	B-DNA	NOUN	B
control	O	NOUN	I
through	O	ADP	O
B	B-protein	NOUN	B
and	I-protein	CCONJ	O
T	I-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Multiple	O	ADJ	B
signals	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
granulocyte-macrophage	I-DNA	ADJ	O
colony-stimulating	I-DNA	ADJ	O
factor	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
proximal	B-DNA	ADJ	B
functional	I-DNA	ADJ	O
promoter	I-DNA	NOUN	O
region	I-DNA	NOUN	O
(	O	PUNCT	O
-620	B-DNA	NUM	O
to	I-DNA	PART	O
+34	I-DNA	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
powerful	O	ADJ	O
enhancer	B-DNA	NOUN	B
located	O	ADJ	O
3	O	NUM	O
kb	O	NOUN	O
upstream	O	ADV	O
,	O	PUNCT	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
to	O	PART	O
TCR	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
proximal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
contains	O	VERB	O
a	O	DET	O
region	O	NOUN	B
termed	O	VERB	O
CLEO	B-DNA	NOUN	B
(	O	PUNCT	O
-54	B-DNA	NUM	O
to	I-DNA	PART	O
-31	I-DNA	NUM	O
)	O	PUNCT	O
that	O	PRON	O
consists	O	VERB	O
of	O	ADP	O
a	O	DET	O
purine-rich	B-DNA	ADJ	B
element	I-DNA	NOUN	B
abutting	O	VERB	O
an	O	DET	O
activator	B-DNA	NOUN	B
protein-1	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
AP-1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-like	I-DNA	ADJ	O
site	I-DNA	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
an	O	DET	O
upstream	B-DNA	ADJ	B
nuclear	I-DNA	ADJ	I
factor-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
site	I-DNA	NOUN	O
(	O	PUNCT	O
-85	B-DNA	NUM	O
to	I-DNA	PART	O
-76	I-DNA	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
CK-1	B-DNA	NOUN	B
element	I-DNA	NOUN	B
(	O	PUNCT	O
-101	B-DNA	NUM	O
to	I-DNA	PART	O
-92	I-DNA	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
weak	O	ADJ	B
inducible	O	ADJ	B
complex	O	NOUN	O
resembling	O	VERB	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
hCLEO	B-DNA	NOUN	B
region	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
calcineurin	B-protein	NOUN	B
could	O	AUX	O
substitute	O	VERB	O
for	O	ADP	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	I
and	O	CCONJ	O
synergize	O	VERB	B
with	O	ADP	O
PMA	O	NOUN	B
to	O	PART	O
activate	O	VERB	B
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
conversely	O	ADV	O
that	O	SCONJ	O
mutant-activated	B-protein	ADJ	B
Ras	I-protein	NOUN	B
could	O	AUX	O
substitute	O	VERB	O
for	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
cooperate	O	VERB	B
with	O	ADP	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
at	O	ADP	O
least	O	ADJ	O
three	O	NUM	O
signals	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
activate	O	VERB	B
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
proximal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
signals	O	NOUN	B
impinge	O	VERB	O
on	O	ADP	O
distinct	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
hCLEO	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
regions	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
affects	O	VERB	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
driving	O	VERB	O
the	O	DET	O
progression	O	NOUN	B
of	O	ADP	O
immune	O	ADJ	B
responsiveness	O	NOUN	I
such	O	ADJ	O
that	O	SCONJ	O
Th2	O	NOUN	B
lymphocyte-mediated	O	ADJ	B
effects	O	NOUN	I
predominate	O	VERB	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
monocytes	B-cell_type	NOUN	B
express	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
IL-10-stimulated	B-protein	ADJ	B
STAT	I-protein	NOUN	I
protein	I-protein	NOUN	I
with	O	ADP	O
an	O	DET	O
M	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
70	B-protein	NUM	O
kDa	I-protein	NOUN	O
that	O	PRON	O
is	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
the	O	DET	O
anti-STAT3	B-protein	ADJ	B
Ab	I-protein	NOUN	I
but	O	CCONJ	O
is	O	AUX	O
not	O	PART	O
observed	O	VERB	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


All	O	DET	O
the	O	DET	O
markers	O	NOUN	B
considered	O	VERB	O
were	O	AUX	O
sufficiently	O	ADV	O
sensitive	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
among	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
Platelet	B-protein	NOUN	B
Factor	I-protein	NOUN	I
IV	I-protein	NUM	I
was	O	AUX	O
the	O	DET	O
most	O	ADV	O
reliable	O	ADJ	O
to	O	PART	O
the	O	DET	O
hormonal	O	ADJ	B
ovulatory	O	ADJ	O
situation	O	NOUN	O
.	O	PUNCT	O


They	O	PRON	O
also	O	ADV	O
display	O	VERB	O
constitutively	O	ADV	B
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
CD3	B-protein	NOUN	B
zeta	I-protein	NOUN	I
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
mitogens	O	NOUN	B
,	O	PUNCT	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivating	O	VERB	B
complex	O	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
occurs	O	VERB	O
with	O	ADP	O
normal	O	ADJ	O
kinetics	O	NOUN	B
in	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Yet	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activating	O	VERB	B
NF-AT	B-protein	NOUN	B
complex	I-protein	NOUN	O
never	O	ADV	O
reach	O	VERB	O
those	O	DET	O
observed	O	VERB	B
in	O	ADP	O
similarly	O	ADV	O
stimulated	O	VERB	B
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
display	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
specific	O	ADJ	O
binding	O	NOUN	B
activity	O	NOUN	I
at	O	ADP	O
the	O	DET	O
NF-AT	B-DNA	NOUN	B
site	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
present	O	ADJ	O
at	O	ADP	O
much	O	ADV	O
lower	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
freshly	O	ADV	O
isolated	O	VERB	B
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
two	O	NUM	O
abnormalities	O	NOUN	B
at	O	ADP	O
the	O	DET	O
NF-AT	B-DNA	NOUN	B
site	I-DNA	NOUN	B
provide	O	VERB	O
a	O	DET	O
potential	O	ADJ	B
mechanism	O	NOUN	B
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
from	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
cross-linking	O	ADJ	B
CD30	B-protein	NOUN	B
with	O	ADP	O
an	O	DET	O
anti-	O	NOUN	O
CD30	B-protein	NOUN	B
-specific	O	ADJ	O
monoclonal	O	ADJ	B
antibody	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mimics	O	VERB	B
the	O	DET	O
described	O	VERB	O
biological	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CD30	B-protein	NOUN	B
ligand	I-protein	NOUN	I
(	O	PUNCT	O
CD30L	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
CD30	B-protein	NOUN	B
-CD30L	B-protein	ADJ	O
interactions	O	NOUN	B
mediate	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
a	O	DET	O
kappa	O	NOUN	O
B-dependent	O	ADJ	B
pathway	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
TNF	B-protein	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
defective	B-DNA	ADJ	B
gene	I-DNA	NOUN	O
in	O	ADP	O
group	O	NOUN	B
II	O	NUM	I
type	O	NOUN	I
II	O	NUM	I
MHC	B-protein	NOUN	I
CID	O	PROPN	B
has	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
termed	O	VERB	O
CIITA	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transactivation	O	NOUN	B
of	O	ADP	O
multiple	B-DNA	ADJ	B
cis	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
S	B-DNA	NOUN	B
and	O	CCONJ	O
X2	B-DNA	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
proximal	I-DNA	ADJ	I
promoter	I-DNA	NOUN	B
in	O	ADP	O
group	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
CID	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
is	O	AUX	O
CIITA	B-protein	NOUN	B
dependent	O	ADJ	B
.	O	PUNCT	O


Since	O	SCONJ	O
CIITA	B-protein	NOUN	B
overexpression	O	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
increase	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
initiation	O	NOUN	B
of	O	ADP	O
CIITA	B-protein	NOUN	B
expression	O	NOUN	B
serves	O	VERB	O
as	O	ADP	O
the	O	DET	O
on-off	O	ADJ	B
switch	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
availability	O	NOUN	B
of	O	ADP	I
downstream	O	ADJ	B
interactor	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
limits	O	VERB	B
transcription	O	NOUN	B
.	O	PUNCT	O


Monocyte	O	NOUN	B
tethering	O	NOUN	I
by	O	ADP	O
P-selectin	B-protein	NOUN	B
regulates	O	VERB	B
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
secretion	O	NOUN	I
.	O	PUNCT	O


Adhesion	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
to	O	PART	O
P-selectin	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
rapidly	O	ADV	O
expressed	O	VERB	B
endothelial	B-protein	ADJ	B
tethering	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
increased	O	VERB	B
the	O	DET	O
secretion	O	NOUN	B
of	O	ADP	O
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
MCP-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
the	O	DET	O
leukocytes	B-cell_type	NOUN	B
when	O	SCONJ	O
they	O	PRON	O
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
P-selectin	B-protein	NOUN	B
,	O	PUNCT	O
through	O	ADP	O
its	O	PRON	O
ligands	O	NOUN	B
on	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
locally	O	ADV	O
regulate	O	VERB	B
cytokine	B-protein	NOUN	B
secretion	O	NOUN	I
in	O	ADP	O
inflamed	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
alpha-like	I-DNA	ADJ	O
globin	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
embryonic	B-DNA	ADJ	B
zeta	I-DNA	NOUN	I
2	I-DNA	NUM	I
and	O	CCONJ	O
adult	B-DNA	ADJ	B
alpha	I-DNA	NOUN	B
,	O	PUNCT	O
during	O	ADP	O
erythroid	O	ADJ	B
development	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
a	O	DET	O
distal	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
,	O	PUNCT	O
HS-40	B-DNA	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
3'NF-E2/AP1	B-DNA	NOUN	O
motif	I-DNA	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
exert	O	VERB	O
both	O	CCONJ	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulatory	O	ADJ	B
effects	O	NOUN	I
on	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2-globin	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
dual	O	ADJ	B
function	O	NOUN	I
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
modulated	O	VERB	B
through	O	ADP	O
differential	O	ADJ	O
binding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
ubiquitous	B-protein	ADJ	O
AP1	I-protein	NOUN	B
factors	I-protein	NOUN	O
and	O	CCONJ	O
the	O	DET	O
erythroid-enriched	B-protein	ADJ	B
NF-E2	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide-stimulated	O	ADJ	O
guanine	O	NOUN	O
nucleotide	O	NOUN	O
exchange	O	NOUN	O
on	O	ADP	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


Circular	O	ADJ	B
dichroism	O	NOUN	I
analysis	O	NOUN	I
reveals	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
induces	O	VERB	B
a	O	DET	O
profound	O	ADJ	O
conformational	O	ADJ	B
change	O	NOUN	I
in	O	ADP	O
p21ras	B-DNA	NOUN	B
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
GDP/GTP	O	NOUN	B
exchange	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
p21ras	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
NO-induced	O	ADJ	B
downstream	O	ADJ	O
signaling	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
endogenous	O	ADJ	B
NO	O	NOUN	B
can	O	AUX	O
activate	O	VERB	B
p21ras	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
cell	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
identify	O	VERB	O
p21ras	B-DNA	NOUN	B
as	O	ADP	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
NO	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
activates	O	VERB	B
p21ras	B-DNA	NOUN	B
by	O	ADP	O
an	O	DET	O
action	O	NOUN	B
which	O	DET	O
mimics	O	VERB	B
that	O	DET	O
of	O	ADP	O
guanine	B-protein	NOUN	B
nucleotide	I-protein	NOUN	I
exchange	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Transient	O	ADJ	B
transfections	O	NOUN	I
using	O	VERB	O
reporter	B-DNA	NOUN	B
constructs	I-DNA	NOUN	I
with	O	ADP	O
multiples	O	NOUN	B
of	O	ADP	O
transcription	B-DNA	NOUN	B
factor	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
from	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
[	O	PUNCT	O
distal	B-protein	ADJ	B
nuclear	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-AT	I-protein	NOUN	O
,	O	PUNCT	O
proximal	B-protein	ADJ	B
NF-AT	I-protein	NOUN	B
,	O	PUNCT	O
AP-1/Octamer	B-protein	NOUN	B
(	O	PUNCT	O
UPS	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
NF-chi	B-protein	NOUN	B
B	I-protein	NOUN	I
(	O	PUNCT	O
TCEd	B-protein	NOUN	B
)	O	PUNCT	O
sites	O	NOUN	B
]	O	PUNCT	O
were	O	AUX	O
performed	O	VERB	O
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
through	O	ADP	O
chi	B-protein	NOUN	B
B	I-protein	NOUN	I
factors	I-protein	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
the	O	DET	O
IL-2	B-cell_line	NOUN	B
producing	I-cell_line	NOUN	O
EBV-B	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
inactive	O	ADJ	B
in	O	ADP	O
the	O	DET	O
non-IL-2-producing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
using	O	VERB	O
protein	O	NOUN	B
extracts	O	NOUN	I
from	O	ADP	O
EBV-B	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
the	O	DET	O
IL-2	B-protein	NOUN	B
NF-chi	B-protein	NOUN	I
B	I-protein	NOUN	B
probe	O	NOUN	I
revealed	O	VERB	O
the	O	DET	O
constitutive	O	ADJ	B
generation	O	NOUN	O
of	O	ADP	O
chi	B-protein	NOUN	B
B	I-protein	NOUN	I
complexes	I-protein	NOUN	I
in	O	ADP	O
IL-2-secreting	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
consisting	O	VERB	O
mainly	O	ADV	O
of	O	ADP	O
heterodimeric	B-protein	ADJ	B
p50/p65	I-protein	NOUN	I
complexes	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
regulators	O	NOUN	B
are	O	AUX	O
targeted	O	VERB	B
by	O	ADP	O
negative	O	ADJ	B
growth	O	NOUN	O
regulatory	O	ADJ	O
signals	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
that	O	DET	O
provided	O	VERB	O
by	O	ADP	O
TGF-beta	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
wild-type	O	ADJ	B
EBV	O	NOUN	O
or	O	CCONJ	O
its	O	PRON	O
transforming	B-protein	VERB	B
latent	I-protein	ADJ	I
membrane	I-protein	NOUN	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
LMP-1	B-protein	NOUN	B
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
1	I-protein	NUM	I
-mediated	O	ADJ	O
growth	O	NOUN	B
inhibition	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Chemical	O	NOUN	B
cross-linking	O	NOUN	I
with	O	ADP	O
125I-labeled	B-protein	ADJ	O
TGF-beta	I-protein	NOUN	B
1	I-protein	NUM	I
showed	O	VERB	O
an	O	DET	O
essentially	O	ADV	O
normal	O	ADJ	O
TGF-beta	B-protein	NOUN	B
receptor	I-protein	NOUN	I
profile	O	NOUN	O
in	O	ADP	O
EBV-positive	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
EBV-negative	I-cell_line	ADJ	B
Burkitt	I-cell_line	NOUN	I
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
these	O	DET	O
receptors	O	NOUN	B
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
functional	O	ADJ	B
in	O	ADP	O
transducing	O	NOUN	B
signals	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
the	O	DET	O
TGF-beta	B-protein	NOUN	B
1	I-protein	NUM	I
-mediated	O	ADJ	O
modulation	O	NOUN	B
of	O	ADP	O
junB	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
LMP-1	B-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
induce	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
cyclin	B-protein	NOUN	B
D2	I-protein	NOUN	I
;	O	PUNCT	O
normal	O	ADJ	B
B	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
EBV-negative	B-cell_line	ADJ	B
Burkitt	I-cell_line	NOUN	I
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
D-type	B-protein	ADJ	B
cyclins	I-protein	NOUN	I
.	O	PUNCT	O


Reactivity	O	NOUN	B
to	O	PART	O
TSHR	B-protein	NOUN	B
peptides	O	NOUN	B
before	O	ADP	O
surgery	O	NOUN	B
was	O	AUX	O
heterogeneous	O	ADJ	B
and	O	CCONJ	O
spanned	O	VERB	O
the	O	DET	O
entire	O	ADJ	O
extracellular	B-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Six	O	NUM	O
to	O	PART	O
8	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
subtotal	O	ADJ	B
thyroidectomy	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
PBMC	B-cell_type	NOUN	B
responding	O	VERB	B
to	O	PART	O
any	O	DET	O
peptide	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
average	O	ADJ	B
number	O	NOUN	O
of	O	ADP	O
recognized	O	VERB	O
peptides	O	NOUN	B
decreased	O	VERB	B
.	O	PUNCT	O


Three	O	NUM	O
to	O	PART	O
6	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
RAI	O	NOUN	B
,	O	PUNCT	O
T	O	NOUN	B
cell	O	NOUN	I
responses	O	NOUN	O
to	O	PART	O
TSHR	B-protein	NOUN	B
peptides	O	NOUN	B
were	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
those	O	DET	O
6-8	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
RAI	O	NOUN	B
therapy	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
still	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
the	O	DET	O
values	O	NOUN	B
on	O	ADP	O
day	O	NOUN	B
0	O	NUM	O
.	O	PUNCT	O


Responses	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
GD	O	NOUN	B
,	O	PUNCT	O
maintained	O	VERB	B
euthyroid	O	ADJ	B
on	O	ADP	O
ATD	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
those	O	DET	O
before	O	ADP	O
surgery	O	NOUN	B
or	O	CCONJ	O
RAI	O	NOUN	B
therapy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
reactivity	O	NOUN	B
of	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
in	O	ADP	O
different	O	ADJ	O
groups	O	NOUN	B
reflected	O	VERB	O
a	O	DET	O
pattern	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
PBMC	B-cell_type	NOUN	B
after	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
response	O	NOUN	O
after	O	ADP	O
RAI	O	NOUN	B
therapy	O	NOUN	B
is	O	AUX	O
probably	O	ADV	O
epitope	O	NOUN	B
specific	O	ADJ	B
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
a	O	DET	O
response	O	NOUN	B
to	O	ADP	O
the	O	DET	O
whole	O	ADJ	O
TSHR	B-protein	NOUN	B
molecule	O	NOUN	O
.	O	PUNCT	O


Circumvention	O	NOUN	B
of	O	ADP	O
tolerance	O	NOUN	B
for	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
T	I-protein	NOUN	I
cell	I-protein	NOUN	I
protein	I-protein	NOUN	I
TCF-1	B-protein	NOUN	B
by	O	ADP	O
immunization	O	NOUN	B
of	O	ADP	O
TCF-1	B-protein	NOUN	B
knock-out	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
events	O	NOUN	I
that	O	PRON	O
underlie	O	VERB	O
the	O	DET	O
well-defined	O	ADJ	O
phenotypic	O	ADJ	B
changes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
differentiating	B-cell_type	VERB	B
thymocyte	I-cell_type	NOUN	B
are	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
candidate	O	NOUN	O
gene	O	NOUN	O
to	O	PART	O
control	O	VERB	O
thymocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
factor-1	I-protein	NOUN	I
(	O	PUNCT	O
TCF-1	B-protein	NOUN	B
)	O	PUNCT	O
*	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
immunization	O	NOUN	B
with	O	ADP	O
a	O	DET	O
recombinant	B-protein	ADJ	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
TCF-1	B-protein	NOUN	B
knock-out	O	ADJ	B
mice	O	NOUN	I
readily	O	ADV	O
yield	O	VERB	O
antiserum	O	NOUN	B
titers	O	NOUN	B
against	O	ADP	O
human	O	ADJ	B
and	O	CCONJ	O
mouse	O	NOUN	B
TCF-1	O	NOUN	B
protein	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
usefulness	O	NOUN	B
of	O	ADP	O
knock-out	O	ADJ	B
mice	O	NOUN	I
for	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
against	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
interest	O	NOUN	O
is	O	AUX	O
underscored	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
an	O	DET	O
in	O	X	B
vivo	O	X	I
footprint	O	NOUN	I
over	O	ADP	O
the	O	DET	O
PuF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
on	O	ADP	O
the	O	DET	O
translocated	O	VERB	B
c-myc	B-DNA	NOUN	I
allele	I-DNA	NOUN	B
in	O	ADP	O
Burkitt	O	NOUN	B
's	O	PART	I
lymphoma	O	NOUN	I
cells	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
with	O	ADP	O
antibody	O	NOUN	B
,	O	PUNCT	O
UV	O	NOUN	B
cross-linking	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
SDS-gel	O	NOUN	B
electrophoresis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Western	O	NOUN	B
analysis	O	NOUN	I
that	O	SCONJ	O
Nm23H2	B-protein	NOUN	B
in	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
nuclear	O	ADJ	O
extracts	O	NOUN	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
c-myc	O	NOUN	B
PuF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
novel	O	ADJ	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
5'-untranslated	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
A	I-DNA	NOUN	O
gamma-globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
second	O	ADJ	O
SSE-like	B-DNA	ADJ	B
element	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
5'-untranslated	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
gamma-gene	B-DNA	NOUN	B
also	O	ADV	O
contributes	O	VERB	O
to	O	PART	O
this	O	DET	O
competitive	O	ADJ	B
silencing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-gene	B-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
marked	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
gamma-promoter	B-DNA	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
with	O	ADP	O
this	O	DET	O
mutation	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
repressor	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
stage	O	NOUN	B
selector	O	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
a	O	DET	O
region	O	NOUN	B
centered	O	VERB	O
on	O	ADP	O
nucleotides	B-DNA	NOUN	B
+13	I-DNA	NUM	O
to	I-DNA	PART	O
+15	I-DNA	NUM	O
.	O	PUNCT	O


The	O	DET	O
repressor	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5'-UTR	B-DNA	NOUN	B
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
tandem	O	ADJ	O
GATA-like	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
appear	O	VERB	O
to	O	PART	O
bind	O	VERB	B
a	O	DET	O
complex	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
proteins	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
is	O	AUX	O
the	O	DET	O
erythroid	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
GATA-1	B-protein	NOUN	B
.	O	PUNCT	O


Coupling	O	NOUN	B
of	O	ADP	O
a	O	DET	O
signal	B-protein	NOUN	B
response	I-protein	NOUN	I
domain	I-protein	NOUN	I
in	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
to	O	PART	O
multiple	O	ADJ	O
pathways	O	NOUN	B
for	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
nuclear	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
is	O	AUX	O
tightly	O	ADV	O
regulated	O	VERB	O
from	O	ADP	O
the	O	DET	O
cytoplasmic	O	ADJ	B
compartment	O	NOUN	B
by	O	ADP	O
an	O	DET	O
inhibitory	B-protein	ADJ	B
subunit	I-protein	NOUN	I
called	O	VERB	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
explore	O	VERB	O
these	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
-dependent	O	ADJ	O
mechanisms	O	NOUN	B
for	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
induction	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	O
novel	O	ADJ	O
mutants	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
that	O	PRON	O
uncouple	O	VERB	O
its	O	PRON	O
inhibitory	O	ADJ	B
and	O	CCONJ	O
signal-transducing	O	ADJ	B
functions	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Specifically	O	ADV	O
,	O	PUNCT	O
removal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
36	I-protein	NUM	O
amino	I-protein	NOUN	B
acids	I-protein	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
failed	O	VERB	B
to	O	PART	O
disrupt	O	VERB	B
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
form	O	VERB	O
latent	O	ADJ	B
complexes	O	NOUN	B
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
deletion	O	NOUN	B
mutation	O	NOUN	I
prevented	O	VERB	B
the	O	DET	O
induced	O	VERB	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
degradative	O	ADJ	B
loss	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
functional	O	ADJ	B
release	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
from	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
Tax-expressing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
introduction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
phosphoserine	O	NOUN	B
mimetic	O	ADJ	B
at	O	ADP	O
these	O	DET	O
sites	O	NOUN	B
rectified	O	VERB	O
this	O	DET	O
functional	O	ADJ	B
defect	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
finding	O	NOUN	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
causal	O	ADJ	O
linkage	O	NOUN	B
between	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
status	O	NOUN	O
and	O	CCONJ	O
proteolytic	O	ADJ	B
stability	O	NOUN	I
of	O	ADP	O
this	O	DET	O
cytoplasmic	B-protein	ADJ	B
inhibitor	I-protein	NOUN	O
.	O	PUNCT	O


Growth	O	NOUN	B
regulation	O	NOUN	I
and	O	CCONJ	O
cellular	O	ADJ	B
changes	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
prostatic	I-cell_line	ADJ	O
cancer	I-cell_line	NOUN	O
LNCaP	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADP	O
induced	O	VERB	B
by	O	ADP	O
T	O	NOUN	B
lymphocyte-conditioned	O	ADJ	I
medium	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
androgen	O	NOUN	B
to	O	PART	O
androgen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
on	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
showed	O	VERB	O
approximately	O	ADV	O
50	O	NUM	O
%	O	NOUN	O
reduction	O	NOUN	B
,	O	PUNCT	O
underlining	O	VERB	O
a	O	DET	O
proliferation	O	NOUN	B
reduction	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Activated	O	VERB	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
were	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
providing	O	VERB	O
the	O	DET	O
modulating	O	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
growth	B-protein	NOUN	B
modulator	I-protein	NOUN	I
was	O	AUX	O
semipurified	O	VERB	B
and	O	CCONJ	O
had	O	AUX	O
an	O	DET	O
estimated	O	VERB	O
molecular	O	ADJ	B
weight	O	NOUN	I
13	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
to	O	PART	O
24	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
Da	O	NOUN	O
.	O	PUNCT	O


Platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
stimulates	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
heparin-binding	B-protein	ADJ	B
epidermal	I-protein	ADJ	I
growth	I-protein	NOUN	I
factor-like	I-protein	ADJ	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


This	O	DET	O
function	O	NOUN	B
of	O	ADP	O
PAF	B-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	O
at	O	ADP	O
nanomolar	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ligand	O	NOUN	B
,	O	PUNCT	O
starting	O	VERB	O
at	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
stimulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
antagonists	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
phorbol	O	NOUN	B
ester-induced	O	ADJ	B
up-regulation	O	NOUN	B
of	O	ADP	O
HB-EGF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
kappa	O	NOUN	B
B	O	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Pretreatment	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
with	O	ADP	O
pertussis	O	NOUN	B
toxin	O	NOUN	I
inhibited	O	VERB	B
these	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
PAF	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
cholera	O	NOUN	B
toxin	O	NOUN	I
had	O	AUX	O
no	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
criteria	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
this	O	DET	O
cell	O	NOUN	B
line	O	NOUN	I
influences	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
an	O	DET	O
isotype-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
transient	O	ADJ	B
transfection	O	NOUN	B
of	O	ADP	O
HLA-DRA	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
DQB	I-DNA	NOUN	B
reporter	I-DNA	NOUN	I
constructs	I-DNA	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
affected	O	VERB	B
factor	O	NOUN	B
operates	O	VERB	O
via	O	ADP	O
cis-elements	B-DNA	NOUN	B
located	O	ADJ	O
between	O	ADP	O
-141	B-DNA	NUM	O
base	I-DNA	NOUN	B
pairs	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Substitution	O	NOUN	B
promoters	O	NOUN	B
were	O	AUX	O
then	O	ADV	O
generated	O	VERB	O
where	O	SCONJ	O
the	O	DET	O
entire	O	ADJ	O
X-box	B-DNA	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
only	O	ADV	O
the	O	DET	O
X1-	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
X2-boxes	I-DNA	NOUN	B
of	O	ADP	O
HLA-DRA	B-DNA	NOUN	B
were	O	AUX	O
replaced	O	VERB	O
with	O	ADP	O
the	O	DET	O
analogous	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
HLA-DQB	B-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
divergent	B-DNA	ADJ	B
X2-box	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
promoters	I-DNA	NOUN	B
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
influencing	O	VERB	O
differential	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
class	I-DNA	NOUN	O
II	I-DNA	NUM	O
isotypes	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ZEBRA	B-protein	NOUN	B
protein	I-protein	NOUN	I
has	O	AUX	O
a	O	DET	O
unique	O	ADJ	O
biological	O	ADJ	B
function	O	NOUN	I
among	O	ADP	O
herpesviral	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
chimeras	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
transactivate	O	VERB	B
model	O	NOUN	B
and	O	CCONJ	O
native	O	ADJ	B
promoters	O	NOUN	B
at	O	ADP	O
equivalent	O	ADJ	B
or	O	CCONJ	O
better	O	ADJ	O
levels	O	NOUN	B
than	O	ADP	O
ZEBRA	B-protein	NOUN	B
itself	O	PRON	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
specificities	O	NOUN	B
of	O	ADP	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
known	O	ADJ	O
biological	O	ADJ	B
functions	O	NOUN	I
of	O	ADP	O
ZEBRA	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
dependent	O	ADJ	O
upon	O	SCONJ	O
the	O	DET	O
nature	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activation	B-protein	NOUN	B
domain	I-protein	NOUN	I
present	I-protein	ADJ	O
within	O	ADP	O
ZEBRA	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
4	I-protein	NUM	I
activates	O	VERB	B
a	O	DET	O
signal	O	NOUN	B
transducer	O	NOUN	I
and	O	CCONJ	O
activator	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	O
(	I-protein	PUNCT	O
Stat	I-protein	NOUN	O
)	I-protein	PUNCT	O
protein	I-protein	NOUN	O
which	O	DET	O
interacts	O	VERB	O
with	O	ADP	O
an	O	DET	O
interferon-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	I
site-like	I-DNA	ADJ	O
sequence	I-DNA	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
I	B-DNA	NOUN	B
epsilon	I-DNA	NOUN	I
exon	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Germ	B-RNA	NOUN	B
line	I-RNA	NOUN	I
C	I-RNA	NOUN	I
transcripts	I-RNA	NOUN	B
can	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
BL-2	B-cell_line	NOUN	B
.	O	PUNCT	O


This	O	DET	O
factor	O	NOUN	B
was	O	AUX	O
designated	O	VERB	O
IL-4	B-protein	NOUN	B
NAF	I-protein	NOUN	B
(	O	PUNCT	O
IL-4-induced	B-protein	ADJ	B
nuclear-activating	I-protein	ADJ	I
factors	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
a	O	DET	O
tyrosine	B-protein	NOUN	B
phosphoprotein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
translocates	O	VERB	B
from	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
upon	O	SCONJ	O
IL-4	B-protein	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
JAK3	B-protein	NOUN	B
with	O	ADP	O
IL-4	B-protein	NOUN	B
Stat	I-protein	NOUN	I
into	O	ADP	O
COS-7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
produced	O	VERB	O
an	O	DET	O
intracellular	O	ADJ	B
activity	O	NOUN	B
which	O	DET	O
bound	O	VERB	O
the	O	DET	O
same	O	ADJ	O
IFN-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	B
site-like	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
comigrated	O	VERB	B
with	O	ADP	O
IL-4	B-protein	NOUN	B
NAF	I-protein	NOUN	B
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


Almost	O	ADV	O
25	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
T-cell	O	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
T-ALL	O	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
tumor-specific	O	ADJ	B
rearrangements	O	NOUN	I
of	O	ADP	O
the	O	DET	O
TAL1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
proposed	O	VERB	O
that	O	SCONJ	O
ectopic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
TAL1	B-protein	NOUN	B
promotes	O	VERB	B
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
T-ALL	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
TAL1	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
leukemic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
most	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
T-ALL	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
many	O	ADJ	O
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
display	O	VERB	O
an	O	DET	O
apparent	O	ADJ	B
TAL1	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
alteration	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
leukemic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
without	O	ADP	O
detectable	O	ADJ	B
TAL1	B-protein	NOUN	B
rearrangements	O	NOUN	B
,	O	PUNCT	O
TAL1	B-protein	NOUN	B
transcription	O	NOUN	B
occurred	O	VERB	O
in	O	ADP	O
either	O	CCONJ	O
a	O	DET	O
monoallelic	O	ADJ	B
(	O	PUNCT	O
3	O	NUM	O
of	O	ADP	O
7	O	NUM	O
patients	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
a	O	DET	O
biallelic	O	ADJ	B
(	O	PUNCT	O
4	O	NUM	O
of	O	ADP	O
7	O	NUM	O
patients	O	NOUN	B
)	O	PUNCT	O
fashion	O	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
TAL1	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
may	O	AUX	O
result	O	VERB	O
from	O	ADP	O
subtle	O	ADJ	O
alterations	O	NOUN	B
in	O	ADP	O
cis-acting	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	I
sequences	I-DNA	NOUN	I
(	O	PUNCT	O
affecting	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
single	B-DNA	ADJ	O
TAL1	I-DNA	NOUN	B
allele	I-DNA	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
changes	O	NOUN	B
in	O	ADP	O
trans-acting	O	ADJ	B
factors	O	NOUN	I
that	O	PRON	O
control	O	VERB	O
TAL1	B-protein	NOUN	B
transcription	O	NOUN	B
(	O	PUNCT	O
affecting	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
TAL1	B-DNA	NOUN	B
alleles	I-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


To	O	PART	O
clarify	O	VERB	O
properties	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
M7	O	NOUN	B
and	O	CCONJ	O
TMD	O	NOUN	B
cases	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
erythroid	O	ADJ	B
markers	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
blasts	B-cell_type	NOUN	B
from	O	ADP	O
six	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
M7	O	NOUN	B
and	O	CCONJ	O
seven	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
TMD	O	NOUN	B
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
found	O	VERB	O
a	O	DET	O
high	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
human	B-RNA	ADJ	B
Ah	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
TCDD	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
individuals	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
blood	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
first	O	ADV	O
investigated	O	VERB	B
in	O	ADP	O
fractions	O	NOUN	B
of	O	ADP	O
nucleated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
revealing	O	VERB	O
predominant	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ah	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
monocyte	B-cell_type	NOUN	B
fraction	I-cell_type	NOUN	I
.	O	PUNCT	O


Then	O	ADV	O
the	O	DET	O
expression	O	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
AhR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
various	O	ADJ	O
hematopoietic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
were	O	AUX	O
examined	O	VERB	O
together	O	ADV	O
with	O	ADP	O
those	O	DET	O
of	O	ADP	O
Arnt	B-protein	NOUN	B
and	O	CCONJ	O
P450IA1	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
AhR	B-protein	NOUN	B
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
was	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
HL60	B-cell_line	NOUN	B
and	O	CCONJ	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
AhR	B-protein	NOUN	B
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
also	O	ADV	O
in	O	ADP	O
the	O	DET	O
eventual	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
environmental	O	ADJ	B
carcinogens	O	NOUN	I
.	O	PUNCT	O


PU.1	B-protein	NOUN	B
and	O	CCONJ	O
Spi-B	B-protein	NOUN	B
have	O	AUX	O
been	O	AUX	O
previously	O	ADV	O
described	O	VERB	O
as	O	ADP	O
being	O	AUX	O
predominantly	O	ADV	O
expressed	O	VERB	B
coordinately	O	ADV	B
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
and	O	CCONJ	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
their	O	PRON	O
expression	O	NOUN	B
in	O	ADP	O
early	O	ADJ	O
hematopoietic	O	ADJ	B
stages	O	NOUN	I
and	O	CCONJ	O
during	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
to	O	PART	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
or	O	CCONJ	O
to	O	PART	O
neutrophils	B-cell_type	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
extensively	O	ADV	O
investigated	O	VERB	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
PU.1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
upregulated	O	VERB	B
during	O	ADP	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
human	B-cell_line	ADJ	B
purified	I-cell_line	VERB	O
CD34+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
murine	B-cell_line	ADJ	B
multipotential	I-cell_line	ADJ	B
FDCP-mix	I-cell_line	NOUN	B
A4	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
PU.1	B-protein	NOUN	B
is	O	AUX	O
upregulated	O	VERB	B
as	O	ADP	O
an	O	DET	O
early	O	ADJ	B
event	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
multipotential	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
PU.1	B-protein	NOUN	B
,	O	PUNCT	O
significant	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
Spi-B	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
only	O	ADV	O
in	O	ADP	O
some	O	DET	O
B-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
spleen	O	NOUN	B
but	O	CCONJ	O
are	O	AUX	O
not	O	PART	O
found	O	VERB	O
in	O	ADP	O
myeloid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
neutrophils	B-cell_type	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
translated	O	VERB	B
Spi-B	B-protein	NOUN	B
protein	I-protein	NOUN	I
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
PU.1	B-DNA	NOUN	B
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
in	O	ADP	O
myeloid	B-DNA	ADJ	B
promoters	I-DNA	NOUN	I
and	O	CCONJ	O
transactivate	O	VERB	B
these	O	DET	O
promoters	B-DNA	NOUN	B
in	O	ADP	O
nonmyeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
although	O	SCONJ	O
PU.1	B-protein	NOUN	B
and	O	CCONJ	O
Spi-B	B-protein	NOUN	B
may	O	AUX	O
bind	O	VERB	B
to	O	PART	O
similar	O	ADJ	O
DNA	O	NOUN	B
control	O	NOUN	I
elements	O	NOUN	I
and	O	CCONJ	O
have	O	AUX	O
redundancy	O	NOUN	B
of	O	ADP	O
transactivation	O	NOUN	B
function	O	NOUN	I
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
significant	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
Spi-B	B-protein	NOUN	B
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
makes	O	VERB	O
it	O	PRON	O
unlikely	O	ADJ	O
that	O	SCONJ	O
Spi-B	B-protein	NOUN	B
plays	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
myeloid	O	ADJ	B
lineage	O	NOUN	I
development	O	NOUN	B
and	O	CCONJ	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
major	O	ADJ	O
positive	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
located	O	ADJ	O
5	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
zeta-globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
transfected	O	VERB	B
into	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
express	O	VERB	O
zeta-globin	B-protein	NOUN	B
,	O	PUNCT	O
comparable	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
activity	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
from	O	ADP	O
the	O	DET	O
-557	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-417	I-DNA	NUM	O
zeta-luciferase	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
alpha-luciferase	B-DNA	NOUN	B
constructs	I-DNA	NOUN	B
when	O	SCONJ	O
no	O	DET	O
enhancers	B-DNA	NOUN	B
or	O	CCONJ	O
the	O	DET	O
alpha-globin	B-DNA	NOUN	B
locus	I-DNA	NOUN	I
enhancers	I-DNA	NOUN	B
were	O	AUX	O
used	O	VERB	O
.	O	PUNCT	O


Reinsertion	O	NOUN	B
of	O	ADP	O
these	O	DET	O
sequences	O	NOUN	B
into	O	ADP	O
zeta-luciferase	B-DNA	NOUN	B
constructs	I-DNA	NOUN	I
missing	O	VERB	B
the	O	DET	O
-417	O	NUM	O
to	O	PART	O
-207	O	NUM	O
region	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
sequences	O	NOUN	B
lack	O	VERB	O
classical	O	ADJ	O
enhancer	O	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


Point	O	NOUN	B
mutation	O	NOUN	I
of	O	ADP	O
a	O	DET	O
CCACC	B-DNA	NOUN	B
site	I-DNA	NOUN	I
at	O	ADP	O
-240	O	NUM	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
-230	B-DNA	NUM	O
GATA-1	I-DNA	NOUN	B
site	I-DNA	NOUN	B
has	O	AUX	O
a	O	DET	O
relatively	O	ADV	O
low	O	ADJ	B
affinity	O	NOUN	B
for	O	ADP	O
GATA-1	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
element	O	NOUN	B
requires	O	VERB	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
additional	B-protein	ADJ	O
unknown	I-protein	ADJ	O
factors	I-protein	NOUN	B
for	O	ADP	O
maximal	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
express	O	VERB	O
multiple	O	ADJ	O
isotypes	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
although	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
well	O	ADV	O
accepted	O	VERB	O
that	O	SCONJ	O
PKCs	B-protein	NOUN	B
have	O	AUX	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
about	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
individual	O	ADJ	B
PKC	B-protein	NOUN	B
isotypes	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
PKC-epsilon	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
transactivation	O	NOUN	B
of	O	ADP	O
NF-AT-1	B-protein	NOUN	B
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
stimulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
a	O	DET	O
constitutively	B-protein	ADV	B
activated	I-protein	VERB	O
p21ras	I-protein	NOUN	B
.	O	PUNCT	O


Phorbol	O	NOUN	B
esters	O	NOUN	I
induce	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
CD69	B-protein	NOUN	B
whereas	O	SCONJ	O
none	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activated	B-protein	VERB	B
PKC	I-protein	NOUN	B
isotypes	I-protein	NOUN	B
tested	O	VERB	B
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
have	O	AUX	O
this	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
selective	O	ADJ	O
functions	O	NOUN	O
for	O	ADP	O
different	O	ADJ	O
PKC	B-protein	NOUN	B
isotypes	I-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
data	O	NOUN	B
comparing	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
activated	B-protein	VERB	B
Ras	I-protein	NOUN	B
and	O	CCONJ	O
PKC	B-protein	NOUN	B
mutants	I-protein	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
PKC-alpha	B-protein	NOUN	B
,	O	PUNCT	O
p21ras	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
PKC-epsilon	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
positioned	O	ADJ	O
linearly	O	ADV	O
on	O	ADP	O
a	O	DET	O
single	O	ADJ	O
signal	O	NOUN	O
transduction	O	NOUN	O
pathway	O	NOUN	O
.	O	PUNCT	O


Steroid	O	NOUN	B
resistance	O	NOUN	I
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
pharmacokinetic	O	ADJ	B
mechanisms	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
steroids	O	NOUN	B
to	O	PART	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
nor	O	CCONJ	O
by	O	ADP	O
defective	O	ADJ	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
this	O	DET	O
receptor	O	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
molecular	O	ADJ	B
abnormality	O	NOUN	I
lies	O	VERB	O
distal	O	ADJ	B
to	O	PART	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
GRE	B-DNA	NOUN	B
is	O	AUX	O
impaired	O	ADJ	B
in	O	ADP	O
steroid-resistant	O	ADJ	B
patients	O	NOUN	B
because	O	SCONJ	O
of	O	ADP	O
a	O	DET	O
reduced	O	VERB	B
number	O	NOUN	O
of	O	ADP	O
receptors	B-protein	NOUN	B
available	O	ADJ	O
for	O	ADP	O
binding	O	VERB	B
to	O	PART	I
DNA	O	NOUN	B
.	O	PUNCT	O


Signaling	O	NOUN	B
by	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
interferons	B-protein	NOUN	B
,	O	PUNCT	O
interleukins	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
involves	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
JAK	B-protein	NOUN	B
kinases	I-protein	NOUN	I
and	O	CCONJ	O
Stat	B-protein	NOUN	B
(	I-protein	PUNCT	O
Signal	I-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	I
are	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
most	O	ADV	O
important	O	ADJ	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
for	O	ADP	O
IL-5	B-protein	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
used	O	VERB	O
here	O	ADV	O
to	O	PART	O
study	O	VERB	B
IL-5	B-protein	NOUN	B
signaling	O	NOUN	I
in	O	ADP	O
a	O	DET	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
cell	I-cell_type	NOUN	O
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
induced	O	VERB	B
rapid	O	ADJ	B
and	O	CCONJ	O
transient	O	ADJ	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
JAK2	B-protein	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
DNA-binding	B-protein	ADJ	B
complexes	I-protein	NOUN	I
were	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
phosphotyrosine	B-protein	NOUN	B
antibody	I-protein	NOUN	I
(	O	PUNCT	O
4G10	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
complex	O	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


Infection	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
of	O	ADP	O
Tat-	O	NOUN	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
viruses	O	NOUN	I
:	O	PUNCT	O
genetic	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
LTR	B-DNA	NOUN	B
and	O	CCONJ	O
tat	B-protein	NOUN	B
mutations	I-protein	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
long-term	I-cell_type	ADJ	B
human	I-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
tat	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
block	O	VERB	B
HIV	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
possible	O	ADJ	O
that	O	SCONJ	O
Tat	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
needed	O	VERB	O
for	O	ADP	O
other	O	ADJ	O
functions	O	NOUN	B
during	O	ADP	O
HIV	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Large	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
viral	B-RNA	ADJ	B
RNA	I-RNA	NOUN	I
and	O	CCONJ	O
particles	O	NOUN	B
were	O	AUX	O
synthesized	O	VERB	B
in	O	ADP	O
infections	O	NOUN	B
established	O	VERB	O
using	O	VERB	O
the	O	DET	O
tat	B-protein	NOUN	B
mutants	I-protein	NOUN	I
that	O	PRON	O
contain	O	VERB	O
modified	B-DNA	ADJ	B
LTRs	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
is	O	AUX	O
inducible	O	ADJ	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
by	O	ADP	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
HMG	B-protein	NOUN	B
I/Y	I-protein	NOUN	I
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
in	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
lacking	O	VERB	O
Oct-2	B-protein	NOUN	B
results	O	VERB	I
in	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
DNA-binding	O	ADJ	B
studies	O	NOUN	B
reveal	O	VERB	O
that	O	SCONJ	O
HMG	O	NOUN	B
I/Y	B-protein	NOUN	B
stimulates	O	VERB	B
Oct-2A	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
HLA-DRA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
Oct-2A	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
antisense	B-DNA	ADJ	B
HMG	I-DNA	NOUN	I
I/Y	I-DNA	NOUN	I
dramatically	O	ADV	O
decreases	O	VERB	B
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	B-cell_type	ADJ	B
virus	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
EBV	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
-infected	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	B
may	O	AUX	O
sustain	O	VERB	O
three	O	NUM	O
distinct	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
virus	O	NOUN	B
latency	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
EBV	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
17	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
EBV-positive	O	ADJ	B
endemic	O	ADJ	B
BL	O	NOUN	B
by	O	ADP	O
immunohistology	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
LMP1	B-protein	NOUN	B
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
variable	O	ADJ	B
proportions	O	NOUN	B
of	O	ADP	O
tumor	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
two	O	NUM	O
cases	O	NOUN	B
and	O	CCONJ	O
EBNA2	B-protein	NOUN	B
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
some	O	DET	O
tumor	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
three	O	NUM	O
other	O	ADJ	O
cases	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
1	I-protein	NUM	I
signaling	O	NOUN	I
pathway	O	NOUN	I
by	O	ADP	O
IL-5	B-protein	NOUN	B
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Eosinophils	B-cell_type	NOUN	B
were	O	AUX	O
purified	O	VERB	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
by	O	ADP	O
discontinuous	O	ADJ	O
Percoll	O	NOUN	B
gradients	O	NOUN	I
and	O	CCONJ	O
stimulated	O	VERB	B
with	O	ADP	O
IL-5	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
Jak	B-protein	NOUN	B
2	I-protein	NUM	I
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
immunoprecipitation	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
immunoblotting	O	NOUN	B
for	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
immunoprecipitated	B-protein	VERB	B
Jak	I-protein	NOUN	B
2	I-protein	NUM	I
obtained	O	VERB	O
from	O	ADP	O
IL-5-stimulated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
underwent	O	VERB	O
autophosphorylation	O	NOUN	B
.	O	PUNCT	O


STAT-1	B-protein	NOUN	B
was	O	AUX	O
tyrosine	O	NOUN	B
phosphorylated	O	ADJ	B
within	O	ADP	O
15	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
IL-5	B-protein	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
induced	O	VERB	B
two	O	NUM	O
proteins	O	NOUN	B
that	O	PRON	O
bound	O	VERB	B
to	O	PART	O
the	O	DET	O
gamma-activating	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
IL-5	B-protein	NOUN	B
activated	O	VERB	B
the	O	DET	O
Jak	B-protein	NOUN	B
2	I-protein	NUM	I
-STAT	B-protein	ADJ	O
1	I-protein	NUM	O
signaling	O	NOUN	B
pathway	O	NOUN	I
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
PHA	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
of	O	ADP	O
PBMCs	B-cell_type	NOUN	B
derived	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
preoperatively	O	ADV	B
was	O	AUX	O
significantly	O	ADV	O
decreased	O	VERB	B
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
data	O	NOUN	B
obtained	O	VERB	O
in	O	ADP	O
healthy	O	ADJ	B
control	O	NOUN	I
individuals	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
the	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
PHA	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
of	O	ADP	O
PBMCs	B-cell_type	NOUN	B
depended	O	VERB	O
upon	O	SCONJ	O
the	O	DET	O
tumour	O	NOUN	B
burden	O	NOUN	B
as	O	ADP	O
manifested	O	VERB	O
by	O	ADP	O
tumour	O	NOUN	B
size	O	NOUN	I
and	O	CCONJ	O
axillary	O	ADJ	B
lymph	O	NOUN	I
node	O	NOUN	I
involvement	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.003	O	NUM	O
in	O	ADP	O
each	O	DET	O
case	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


After	O	ADP	O
an	O	DET	O
additional	O	ADJ	O
6	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
i.e.	O	X	O
12	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
surgery	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
PHA	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
of	O	ADP	O
PBMCs	B-cell_type	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
after	O	ADP	O
adjuvant	O	ADJ	B
chemotherapy	O	NOUN	I
with	O	ADP	O
CMF	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
those	O	DET	O
receiving	O	VERB	O
continued	O	VERB	O
adjuvant	O	ADJ	B
tamoxifen	O	NOUN	B
treatment	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
all	O	DET	O
patients	O	NOUN	B
still	O	ADV	O
significantly	O	ADV	O
decreased	O	VERB	B
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
healthy	O	ADJ	B
controls	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
out	O	ADP	O
of	O	ADP	O
59	O	NUM	O
patients	O	NOUN	B
whose	O	DET	O
PBMCs	B-cell_type	NOUN	B
showed	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
PHA	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
within	O	ADP	O
the	O	DET	O
first	O	ADJ	O
12	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
surgery	O	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
one	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
presented	O	VERB	O
with	O	ADP	O
disease	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
DNA-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
abolished	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
in	O	ADP	O
human	O	ADJ	B
B	O	NOUN	O
cell	O	NOUN	O
nuclear	O	ADJ	O
extract	O	NOUN	O
and	O	CCONJ	O
decreased	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	O
to	O	PART	O
a	O	DET	O
basal	O	ADJ	B
level	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
DP	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
element	I-DNA	NOUN	O
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
the	O	DET	O
element	O	NOUN	B
in	O	ADP	O
the	O	DET	O
DQ	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
NF-E1	B-protein	NOUN	B
(	O	PUNCT	O
YY1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Core	B-protein	NOUN	B
binding	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
CBF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
polyomavirus	B-protein	NOUN	B
enhancer-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
2	I-protein	NUM	I
and	O	CCONJ	O
SL3	B-protein	NOUN	B
enhancer	I-protein	NOUN	I
factor	I-protein	NOUN	I
1	I-protein	NUM	I
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
mammalian	B-protein	ADJ	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
an	O	DET	O
element	O	NOUN	B
termed	O	VERB	O
the	O	DET	O
core	O	NOUN	B
within	O	ADP	O
the	O	DET	O
enhancers	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
leukemia	O	NOUN	O
virus	O	NOUN	O
family	O	NOUN	O
of	O	ADP	O
retroviruses	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
core	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
SL3	O	NOUN	B
virus	O	NOUN	I
are	O	AUX	O
important	O	ADJ	O
genetic	O	ADJ	B
determinants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ability	O	NOUN	B
of	O	ADP	O
this	O	DET	O
virus	O	NOUN	B
to	O	PART	O
induce	O	VERB	B
T-cell	O	NOUN	B
lymphomas	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
viral	B-DNA	ADJ	B
long	I-DNA	ADJ	I
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
genes	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
CBF	B-protein	NOUN	B
alpha	I-protein	NOUN	O
subunit	I-protein	NOUN	O
is	O	AUX	O
AML1	B-protein	NOUN	B
,	O	PUNCT	O
also	O	ADV	O
called	O	VERB	O
Cbf	B-protein	NOUN	B
alpha	I-protein	NOUN	I
2	I-protein	NUM	I
.	O	PUNCT	O


Three	O	NUM	O
different	O	ADJ	O
isoforms	O	NOUN	B
of	O	ADP	O
CBF	B-protein	NOUN	B
beta	I-protein	NOUN	B
were	O	AUX	O
also	O	ADV	O
tested	O	VERB	B
for	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
on	O	ADP	O
the	O	DET	O
SL3	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
at	O	ADV	O
least	O	ADJ	O
in	O	ADP	O
certain	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
maximum	O	ADJ	O
activity	O	NOUN	B
of	O	ADP	O
CBF	B-protein	NOUN	B
required	O	VERB	O
both	O	DET	O
subunits	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
difference	O	NOUN	O
strongly	O	ADV	O
affects	O	VERB	O
transcription	O	NOUN	B
in	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
leukemogenicity	O	NOUN	B
of	O	ADP	O
SL3	B-DNA	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
combination	O	NOUN	O
of	O	ADP	O
CBF	B-protein	NOUN	B
alpha	I-protein	NOUN	B
and	O	CCONJ	O
CBF	B-protein	NOUN	B
beta	I-protein	NOUN	B
subunits	O	NOUN	I
that	O	PRON	O
we	O	PRON	O
tested	O	VERB	B
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
distinguish	O	VERB	O
the	O	DET	O
1-bp	O	ADJ	O
difference	O	NOUN	O
in	O	ADP	O
transcription	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-10	I-protein	NUM	O
inhibits	O	VERB	B
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
activation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
now	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
monocytes	O	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
or	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
inhibits	O	VERB	B
nuclear	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
inflammatory	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
.	O	PUNCT	O
Several	O	ADJ	O
other	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
including	O	VERB	O
NF-	O	NOUN	B
IL-6	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
AP-2	B-protein	NOUN	B
,	O	PUNCT	O
GR	B-protein	NOUN	B
,	O	PUNCT	O
CREB	B-protein	NOUN	B
,	O	PUNCT	O
Oct-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp-1	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
IL-10	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
selective	O	ADJ	O
inhibition	O	NOUN	B
by	O	ADP	O
IL-10	B-protein	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	B
occurs	O	VERB	O
rapidly	O	ADV	B
and	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
correlates	O	VERB	B
well	O	ADV	O
with	O	ADP	O
IL-10	B-protein	NOUN	B
's	O	PART	O
cytokine	B-protein	NOUN	B
synthesis	O	NOUN	I
inhibitory	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
kinetics	O	NOUN	B
and	O	CCONJ	O
dose	O	NOUN	B
responsiveness	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
compounds	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
tosylphenylalanyl	O	NOUN	B
chloromethyl	O	NOUN	I
ketone	O	NOUN	B
and	O	CCONJ	O
pyrrolidinedithiocarbamate	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
selectively	O	ADV	O
inhibit	O	VERB	B
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	O
block	O	VERB	O
cytokine	O	NOUN	O
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
LPS-stimulated	B-cell_line	ADJ	B
monocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
IL-10	B-protein	NOUN	B
suppression	O	NOUN	B
of	O	ADP	O
cytokine	O	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
controlling	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	B
involved	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
growth	O	NOUN	B
control	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
LMP-1	B-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
DNA	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
TR2RE-SV40	B-DNA	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
TR2	B-protein	NOUN	B
orphan	I-protein	NOUN	I
receptor	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid-thyroid	B-protein	ADJ	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
simian	B-DNA	ADJ	B
virus	I-DNA	NOUN	I
40	I-DNA	NUM	O
(	I-DNA	PUNCT	O
SV40	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
+55	I-DNA	NUM	O
region	I-DNA	NOUN	O
(	O	PUNCT	O
nucleotide	B-DNA	NOUN	B
numbers	I-DNA	NOUN	I
368-389	I-DNA	NUM	O
,	O	PUNCT	O
5'-GTTAAGGTTCGTAGGTCATGGA-3	O	NOUN	O
'	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
in	O	X	B
vitro	O	X	I
translated	O	VERB	B
TR2	B-protein	NOUN	B
orphan	I-protein	NOUN	I
receptor	I-protein	NOUN	I
with	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
67	B-protein	NUM	O
kilodaltons	I-protein	NOUN	B
,	O	PUNCT	O
showed	O	VERB	O
a	O	DET	O
specific	O	ADJ	O
binding	O	NOUN	B
with	O	ADP	O
high	O	ADJ	O
affinity	O	NOUN	B
(	O	PUNCT	O
dissociation	O	NOUN	B
constant	O	NOUN	I
=	O	ADJ	O
9	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
this	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
this	O	DET	O
TR2RE-SV40	B-DNA	NOUN	O
can	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
repressor	O	NOUN	B
to	O	PART	O
suppress	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
SV40	B-DNA	NOUN	B
early	I-DNA	ADJ	B
and	I-DNA	CCONJ	O
late	I-DNA	ADJ	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
CBF	B-RNA	NOUN	B
beta-MYH11	I-RNA	NOUN	B
fusion	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
by	O	ADP	O
RT-PCR	O	NOUN	B
in	O	ADP	O
myelomonocytic	O	ADJ	B
leukemias	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
eosinophilia	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
their	O	PRON	O
presence	O	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
morphology	O	NOUN	B
.	O	PUNCT	O


Fifty-three	O	NUM	O
cases	O	NOUN	B
(	O	PUNCT	O
11	O	NUM	O
AML	O	NOUN	B
M4Eo	O	NOUN	B
;	O	PUNCT	O
1	O	NUM	O
AML	O	NOUN	B
M4	O	NOUN	B
with	O	ADP	O
atypical	B-cell_type	ADJ	B
abnormal	I-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	O
(	O	PUNCT	O
AML	O	NOUN	B
M4	O	NOUN	I
``	O	PUNCT	O
Eo	O	NOUN	B
''	O	PUNCT	I
)	O	PUNCT	O
;	O	PUNCT	O
29	O	NUM	O
AML	O	NOUN	B
M4	O	NOUN	O
;	O	PUNCT	O
8	O	NUM	O
AML	O	NOUN	B
M5	O	NOUN	O
;	O	PUNCT	O
3	O	NUM	O
CMML	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
AML	O	NOUN	B
M2	O	NOUN	B
with	O	ADP	O
eosinophilia	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
29	O	NUM	O
(	O	PUNCT	O
10	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
AML	O	NOUN	B
M4	O	NOUN	O
without	O	ADP	O
abnormal	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
were	O	AUX	O
CBF	B-DNA	NOUN	B
beta	I-DNA	NOUN	B
-MYH11	B-DNA	NOUN	O
positive	O	ADJ	B
,	O	PUNCT	O
1	O	NUM	O
of	O	ADP	O
which	O	DET	O
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
any	O	DET	O
apparent	O	ADJ	B
chromosome	B-DNA	NOUN	O
16	I-DNA	NUM	O
abnormalities	O	NOUN	B
by	O	ADP	O
classical	O	ADJ	O
metaphase	O	NOUN	O
analysis	O	NOUN	O
(	O	PUNCT	O
2	O	NUM	O
not	O	PART	O
tested	O	VERB	B
)	O	PUNCT	O
.	O	PUNCT	O


Both	O	DET	O
cases	O	NOUN	B
tested	O	VERB	B
also	O	ADV	O
showed	O	VERB	O
MYH11	B-DNA	NOUN	B
genomic	O	ADJ	B
rearrangement	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stably	O	ADV	B
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
tat	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
(	O	PUNCT	O
HeLa-tat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Tat	B-protein	NOUN	B
protein	I-protein	NOUN	I
enhanced	O	VERB	B
both	O	CCONJ	O
TNF	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
TNF	B-protein	NOUN	B
-mediated	O	ADJ	O
cytotoxicity	O	NOUN	B
.	O	PUNCT	O


TNF	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
cytotoxicity	O	NOUN	B
involves	O	VERB	O
the	O	DET	O
intracellular	O	ADJ	B
formation	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediates	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
Mn-SOD	B-protein	NOUN	B
RNA	O	NOUN	I
protein	O	NOUN	I
levels	O	NOUN	O
and	O	CCONJ	O
activity	O	NOUN	B
were	O	AUX	O
markedly	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
Tat	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
experiments	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
HIV-1	B-protein	NOUN	B
Tat	I-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
to	O	PART	O
suppress	O	VERB	B
Mn-SOD	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
induce	O	VERB	B
pro-oxidative	O	ADJ	B
conditions	O	NOUN	O
reflected	O	VERB	O
by	O	ADP	O
a	O	DET	O
drop	O	NOUN	B
in	O	ADP	O
reduced	O	VERB	B
glutathione	O	NOUN	O
(	O	PUNCT	O
GSH	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
GSH	O	NOUN	B
:	O	PUNCT	O
oxidized	O	VERB	B
GSH	O	NOUN	I
(	O	PUNCT	O
GSSG	O	NOUN	B
)	O	PUNCT	O
ratio	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
protein	I-protein	NOUN	I
2	I-protein	NUM	I
transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
latent	B-DNA	ADJ	B
membrane	I-DNA	NOUN	I
protein	I-DNA	NOUN	I
1	I-DNA	NUM	I
promoter	I-DNA	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
J	B-protein	NOUN	B
kappa	I-protein	NOUN	I
and	O	CCONJ	O
PU.1	B-protein	NOUN	B
.	O	PUNCT	O


EBNA-2	B-protein	NOUN	B
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
the	O	DET	O
cellular	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
J	B-protein	NOUN	I
kappa	I-protein	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
recruited	O	VERB	O
to	O	PART	O
promoters	B-DNA	NOUN	B
containing	O	VERB	O
the	O	DET	O
GTGGGAA	O	NOUN	B
J	B-DNA	NOUN	I
kappa	I-DNA	NOUN	I
recognition	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
previously	O	ADV	O
characterized	O	VERB	B
factors	O	NOUN	B
J	B-protein	NOUN	O
kappa	I-protein	NOUN	O
,	O	PUNCT	O
PU.1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
AML1	B-protein	NOUN	B
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
LMP-1	B-DNA	NOUN	B
E2RE	I-DNA	NOUN	B
,	O	PUNCT	O
along	O	ADP	O
with	O	ADP	O
six	O	NUM	O
other	O	ADJ	O
unidentified	O	ADJ	O
factors	O	NOUN	B
(	O	PUNCT	O
LBF2	B-protein	NOUN	B
to	O	PART	O
LBF7	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


LBF4	B-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
105	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
probably	O	ADV	O
unrelated	O	ADJ	O
to	O	PART	O
PU.1	B-protein	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AML1-	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
LBF4-binding	I-DNA	ADJ	B
sites	I-DNA	NOUN	I
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
EBNA-2	B-protein	NOUN	B
transactivation	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PU.1-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
completely	O	ADV	O
eliminated	O	VERB	O
EBNA-2	B-protein	NOUN	B
responses	O	NOUN	B
.	O	PUNCT	O


LBF3	B-protein	NOUN	B
,	O	PUNCT	O
LBF5	B-protein	PROPN	B
,	O	PUNCT	O
LBF6	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
LBF7	B-protein	NOUN	B
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
involved	O	VERB	O
,	O	PUNCT	O
since	O	SCONJ	O
their	O	PRON	O
binding	O	VERB	B
sites	O	NOUN	I
also	O	ADV	O
contribute	O	VERB	O
to	O	PART	O
EBNA-2	B-protein	NOUN	B
responsiveness	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
lymphocyte	B-protein	NOUN	B
GCII	I-protein	NOUN	B
is	O	AUX	O
altered	O	VERB	O
in	O	ADP	O
adolescent	O	ADJ	B
MDD	O	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
marker	O	NOUN	B
for	O	ADP	O
response	O	NOUN	B
to	O	PART	O
SRIs	O	NOUN	B
.	O	PUNCT	O


Only	O	ADV	O
SRI	O	NOUN	B
responders	O	NOUN	B
showed	O	VERB	O
GCII	B-protein	NOUN	B
sites/cell	O	NOUN	O
upregulated	O	VERB	B
after	O	ADP	O
6	O	NUM	O
weeks	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
(	O	PUNCT	O
t	O	NOUN	O
=	O	ADJ	O
2.1	O	NUM	O
,	O	PUNCT	O
df	O	NOUN	O
=	O	ADJ	O
10	O	NUM	O
;	O	PUNCT	O
p	O	X	O
<	O	X	O
.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
kappa	B-protein	NOUN	B
3	I-protein	NUM	I
binding	I-protein	NOUN	I
factor	I-protein	NOUN	I
contains	O	VERB	O
NFATp	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
cyclosporin-sensitive	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
required	O	VERB	O
for	O	ADP	O
interleukin-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
NFATp	B-protein	NOUN	B
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
interleukin-2	B-protein	NOUN	B
and	O	CCONJ	O
TNF	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
factor	O	NOUN	B
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
coordinate	O	NOUN	O
induction	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
starting	O	VERB	O
at	O	ADP	O
the	O	DET	O
earliest	O	ADJ	O
stages	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
and	O	CCONJ	O
specificity	O	NOUN	B
of	O	ADP	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
leukemia/B	B-cell_line	ADJ	B
lymphoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
specificity	O	NOUN	B
of	O	ADP	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
for	O	ADP	O
cells	O	NOUN	B
in	O	ADP	O
the	O	DET	O
granulocyte-macrophage	O	ADJ	B
lineage	O	NOUN	I
was	O	AUX	O
reexamined	O	VERB	O
in	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
established	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Philadelphia	O	NOUN	B
chromosome-positive	O	ADJ	I
chronic	O	ADJ	I
myeloid	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Cell	O	NOUN	B
lines	O	NOUN	I
that	O	PRON	O
expressed	O	VERB	B
MNDA	B-protein	NOUN	B
exhibited	O	VERB	O
myeloid	O	ADJ	B
cell	O	NOUN	I
features	O	NOUN	B
and	O	CCONJ	O
granulocyte	O	NOUN	B
or	O	CCONJ	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
while	O	SCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
exhibiting	O	VERB	O
properties	O	NOUN	B
of	O	ADP	O
very	O	ADV	O
early	O	ADJ	O
stage	O	NOUN	B
cells	O	NOUN	I
or	O	CCONJ	O
multipotential	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
MNDA	B-protein	NOUN	B
.	O	PUNCT	O


Changes	O	NOUN	B
in	O	ADP	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
occurred	O	VERB	O
slowly	O	ADV	O
(	O	PUNCT	O
hours	O	NOUN	O
to	O	PART	O
days	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
MNDA	B-protein	NOUN	B
could	O	AUX	O
mediate	O	VERB	O
changes	O	NOUN	B
realized	O	VERB	B
over	O	ADP	O
a	O	DET	O
long	O	ADJ	O
period	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
also	O	ADV	O
reveal	O	VERB	O
a	O	DET	O
discordance	O	NOUN	B
in	O	ADP	O
certain	O	ADJ	O
MNDA	B-cell_line	NOUN	B
positive	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
between	O	ADP	O
steady-state	O	ADJ	B
levels	O	NOUN	O
or	O	CCONJ	O
changes	O	NOUN	B
in	O	ADP	O
levels	O	NOUN	B
of	O	ADP	I
protein	O	NOUN	B
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
one	O	NUM	O
point	O	NOUN	O
.	O	PUNCT	O


Changes	O	NOUN	B
in	O	ADP	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
opposing	O	VERB	O
macrophage	O	NOUN	B
differentiation	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Trans-activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TP1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
BamHI	B-DNA	NOUN	B
C	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
has	O	AUX	O
already	O	ADV	O
been	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
detail	O	NOUN	O
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
via	O	ADP	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
and	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
direct	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
EBNA-2	B-protein	NOUN	B
type	I-protein	NOUN	O
A	I-protein	NOUN	O
(	O	PUNCT	O
of	O	ADP	O
EBV	O	NOUN	B
type	O	NOUN	O
1	O	NUM	O
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
DNA	O	NOUN	B
.	O	PUNCT	O


Various	O	ADJ	O
reports	O	NOUN	B
have	O	AUX	O
delineated	O	VERB	O
the	O	DET	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LMP	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
through	O	ADP	O
which	O	DET	O
EBNA-2	B-protein	NOUN	B
mediates	O	VERB	O
trans-activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
protein-binding	B-DNA	ADJ	B
region	I-DNA	NOUN	I
on	O	ADP	O
the	O	DET	O
LMP	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
within	O	ADP	O
a	O	DET	O
42	B-DNA	NUM	O
bp	I-DNA	NOUN	O
fragment	I-DNA	NOUN	B
encompassing	O	NOUN	O
nucleotides	O	NOUN	B
-135	O	NUM	O
to	O	PART	O
-176	O	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
LMP	B-DNA	NOUN	B
transcriptional	I-DNA	ADJ	O
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
.	O	PUNCT	O


No	O	DET	B
significant	O	ADJ	I
differences	O	NOUN	O
between	O	ADP	O
EBNA-2	B-protein	NOUN	B
-positive	O	ADJ	O
and	O	CCONJ	O
EBNA-2	B-protein	NOUN	B
-negative	O	ADJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
the	O	DET	O
gel	O	NOUN	B
retardation	O	NOUN	I
assay	O	NOUN	I
under	O	ADP	O
conditions	O	NOUN	O
that	O	PRON	O
clearly	O	ADV	O
showed	O	VERB	O
binding	O	NOUN	B
of	O	ADP	O
EBNA-2A	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
TP1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
sucrose	O	NOUN	B
gradient	O	NOUN	O
fractions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
gel	O	NOUN	B
retardation	O	NOUN	I
assay	O	NOUN	I
provided	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
LMP	B-protein	NOUN	B
promoter-binding	I-protein	ADJ	I
proteins	I-protein	NOUN	I
form	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
of	O	ADP	O
higher	O	ADJ	B
M	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
EBNA-2-positive	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
extracts	O	NOUN	O
.	O	PUNCT	O


Simultaneous	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
Ig	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
reduction	O	NOUN	B
of	O	ADP	O
surface	O	NOUN	B
MHC	B-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
expression	O	NOUN	B
by	O	ADP	O
IL-6	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
IL-6-induced	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
resemble	O	VERB	O
plasma	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
ultrastructure	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
reduced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
MHC	I-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
.	O	PUNCT	O


Enhanced	O	VERB	B
Ig	B-protein	NOUN	B
synthesis	O	NOUN	I
is	O	AUX	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
coordinated	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	O
of	O	ADP	O
Ig	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
without	O	ADP	O
promoter	O	NOUN	B
or	O	CCONJ	O
isotype	O	NOUN	B
specificity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
differential	O	ADJ	B
accumulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mRNA	B-RNA	NOUN	B
encoding	O	VERB	B
the	O	DET	O
secreted	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
Ig	B-protein	NOUN	B
heavy	I-protein	ADJ	I
chain	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	B-DNA	ADJ	B
interleukin-3	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL-3	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
is	O	AUX	O
expressed	O	VERB	B
almost	O	ADV	O
exclusively	O	ADV	O
in	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
transcription	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
generated	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
reporter	O	NOUN	B
constructs	O	NOUN	I
containing	O	VERB	O
different	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
5	I-DNA	NUM	I
'	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
3	I-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-1	B-protein	NOUN	I
could	O	AUX	O
bind	O	VERB	B
to	O	PART	O
this	O	DET	O
positive	O	ADJ	B
activator	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
CK-1/CK-2	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
that	O	PRON	O
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
many	O	ADJ	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
acted	O	VERB	B
as	O	ADP	O
a	O	DET	O
repressor	O	NOUN	B
of	O	ADP	O
basal	O	ADJ	B
level	O	NOUN	O
expression	O	NOUN	B
when	O	SCONJ	O
cloned	O	VERB	B
upstream	O	ADV	B
of	O	ADP	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
but	O	CCONJ	O
were	O	AUX	O
also	O	ADV	O
inducible	O	ADJ	B
by	O	ADP	O
PMA	O	NOUN	B
/PHA	B-protein	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
transcripts	O	NOUN	B
of	O	ADP	O
PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	I
A	I-protein	NOUN	I
and	O	CCONJ	O
mouse	B-protein	NOUN	B
AML1/PEBP2	I-protein	NOUN	B
alpha	I-protein	NOUN	B
B	I-protein	NOUN	I
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
thymuses	O	NOUN	B
from	O	ADP	O
day	O	NOUN	B
16	O	NUM	O
embryos	O	NOUN	B
and	O	CCONJ	O
newborns	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
4-week-old	O	ADJ	O
adult	O	ADJ	B
mice	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
implication	O	NOUN	B
of	O	ADP	O
mouse	O	NOUN	B
AML1/PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	B
B	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
other	O	ADJ	O
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
T-cell	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
is	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
myeloid	O	ADJ	B
leukemogenesis	O	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
glucocorticoids	O	NOUN	B
on	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


TNF-alpha	O	NOUN	B
,	O	PUNCT	O
IL-1	O	NOUN	B
beta	O	NOUN	I
and	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
treatment	O	NOUN	B
increased	O	VERB	B
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF	O	NOUN	B
kappa	O	NOUN	I
B	O	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
up	O	ADV	O
to	O	PART	O
200	O	NUM	O
%	O	NOUN	O
but	O	CCONJ	O
decreased	O	VERB	B
CREB	B-protein	NOUN	B
binding	O	NOUN	B
(	O	PUNCT	O
38	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
over	O	ADP	O
a	O	DET	O
60-min	O	ADJ	O
time	O	NOUN	B
course	O	NOUN	I
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
produced	O	VERB	O
a	O	DET	O
rapid	O	ADJ	B
and	O	CCONJ	O
sustained	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
binding	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
concomitant	O	ADJ	B
40-50	O	NUM	O
%	O	NOUN	O
decrease	O	NOUN	B
in	O	ADP	O
AP-1	O	NOUN	B
,	O	PUNCT	O
NF	O	NOUN	B
kappa	O	NOUN	I
B	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
CREB	O	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
that	O	PRON	O
was	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
combined	O	ADJ	O
dexamethasone	O	NOUN	B
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
or	O	CCONJ	O
PMA	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
GR	B-protein	NOUN	B
within	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
interacts	O	VERB	O
with	O	ADP	O
cytokine-stimulated	B-protein	ADJ	B
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
by	O	ADP	O
the	O	DET	O
process	O	NOUN	B
of	O	ADP	O
cross	O	NOUN	B
coupling	O	NOUN	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
through	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TcR	B-protein	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
high	O	ADJ	O
doses	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
peptide	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
long-lived	O	ADJ	B
state	O	NOUN	I
of	O	ADP	O
nonresponsiveness	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
called	O	VERB	O
anergy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
TcR	B-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
is	O	AUX	O
downmodulated	O	VERB	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
CD2	B-protein	NOUN	B
and	I-protein	CCONJ	O
CD25	I-protein	NOUN	B
receptors	I-protein	NOUN	I
are	O	AUX	O
increased	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
restimulated	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
pattern	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
T-cell-specific	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
beta	O	NOUN	B
chain	O	NOUN	I
of	O	ADP	I
the	O	DET	I
TcR	B-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
measured	O	VERB	B
binding	O	VERB	B
to	O	PART	O
a	O	DET	O
TCF-1	B-DNA	NOUN	B
site	I-DNA	NOUN	B
is	O	AUX	O
the	O	DET	O
same	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
resting	B-cell_type	VERB	B
,	I-cell_type	PUNCT	O
activated	I-cell_type	VERB	B
,	I-cell_type	PUNCT	O
and	I-cell_type	CCONJ	O
anergized	I-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	O
is	O	AUX	O
elevated	O	VERB	B
by	O	ADP	O
a	O	DET	O
zinc	O	NOUN	B
containing	O	VERB	O
trace	O	NOUN	B
element	O	NOUN	I
preparation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
enhancement	O	NOUN	B
by	O	ADP	O
BDP	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
either	O	CCONJ	O
for	O	ADP	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
gcRs	B-protein	NOUN	B
or	O	CCONJ	O
in	O	ADP	O
experiments	O	NOUN	B
when	O	SCONJ	O
the	O	DET	O
lymphocytes	B-cell_type	NOUN	B
were	O	AUX	O
stimulated	O	VERB	B
by	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-6	I-protein	NUM	O
.	O	PUNCT	O


The	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
whether	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
could	O	AUX	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
increasing	O	VERB	B
unresponsiveness	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
lymphatic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
CLL	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
combination	O	NOUN	B
chemotherapy	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
conclusion	O	NOUN	O
is	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
corticoid	O	NOUN	B
resistance	O	NOUN	B
in	O	ADP	O
mouse	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
human	I-cell_line	ADJ	B
lymphoma	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
in	O	ADP	O
culture	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
is	O	AUX	O
greatly	O	ADV	O
inducible	O	ADJ	B
in	O	ADP	O
pre-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
bacterial	O	ADJ	B
lipopolysaccharide	O	NOUN	B
and	O	CCONJ	O
interleukin-1	B-protein	NOUN	B
but	O	CCONJ	O
specific	O	ADJ	O
complexes	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
at	O	ADP	O
all	O	DET	O
stages	O	NOUN	B
of	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	O
tested	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
footprinted	B-DNA	ADJ	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
is	O	AUX	O
homologous	O	ADJ	O
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
AP1	I-DNA	NOUN	I
motif	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
components	O	NOUN	I
of	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
are	O	AUX	O
specifically	O	ADV	O
competed	O	VERB	O
by	O	ADP	O
an	O	DET	O
AP1	B-DNA	NOUN	B
consensus	I-DNA	NOUN	B
motif	I-DNA	NOUN	I
and	O	CCONJ	O
were	O	AUX	O
shown	O	VERB	O
by	O	ADP	O
supershift	O	NOUN	B
to	O	PART	O
include	O	VERB	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
is	O	AUX	O
an	O	DET	O
AP1	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
Jun	B-protein	NOUN	B
and	I-protein	CCONJ	O
Fos	I-protein	NOUN	B
families	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
light	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Methylation	O	NOUN	B
studies	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
tal-15	B-DNA	NOUN	B
'	I-DNA	PART	O
GC-rich	I-DNA	ADJ	B
region	I-DNA	NOUN	I
behaves	O	VERB	O
like	O	ADP	O
a	O	DET	O
CpG	B-DNA	NOUN	B
island	I-DNA	NOUN	I
,	O	PUNCT	O
hypomethylated	O	VERB	B
in	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
methylated	O	VERB	B
de	O	X	O
novo	O	X	O
on	O	ADP	O
transcriptionally	B-DNA	ADV	B
inactive	I-DNA	ADJ	O
alleles	I-DNA	NOUN	B
in	O	ADP	O
established	B-cell_line	ADJ	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
distinct	O	ADJ	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
the	O	DET	O
different	O	ADJ	O
tal-1	B-DNA	NOUN	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
resting	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
cdc2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
T-lymphocytes	B-cell_type	NOUN	B
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
reentered	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
specific	O	ADJ	O
mitogens	O	NOUN	B
.	O	PUNCT	O


Association	O	NOUN	B
of	O	ADP	O
alterations	O	NOUN	B
in	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
moieties	I-protein	NOUN	I
with	O	ADP	O
HIV	O	NOUN	B
type	O	NOUN	I
1	O	NUM	I
proviral	O	ADJ	B
latency	O	NOUN	I
in	O	ADP	O
certain	O	ADJ	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
replication	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
complex	O	ADJ	B
array	O	NOUN	O
of	O	ADP	O
virally	B-protein	ADV	B
encoded	I-protein	VERB	B
and	I-protein	CCONJ	O
cellular	I-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
predominance	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
moieties	I-protein	NOUN	B
and	O	CCONJ	O
possibly	O	ADV	O
p50	B-protein	NOUN	B
homodimers	I-protein	NOUN	I
or	O	CCONJ	O
closely	O	ADV	O
related	O	ADJ	O
species	O	NOUN	B
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
the	O	DET	O
p50-p56	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
the	O	DET	O
predominant	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
species	O	NOUN	B
in	O	ADP	O
most	O	ADJ	O
T	B-cell_type	NOUN	B
lymphocytic	I-cell_type	ADJ	I
and	I-cell_type	CCONJ	O
monocytic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Regulation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
B-lymphocytes	B-cell_type	NOUN	B
]	O	PUNCT	O


Since	O	SCONJ	O
most	O	ADJ	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
immortalized	O	VERB	B
with	O	ADP	O
EBV	O	NOUN	B
virus	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
to	O	PART	O
produce	O	VERB	O
interleukin-2	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
typical	O	ADJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
cytokine	I-protein	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
different	O	ADJ	O
elements	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
in	O	ADP	O
such	O	ADJ	O
clones	O	NOUN	B
by	O	ADP	O
transfection	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
regulating	O	VERB	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
persistence	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
monocytes	B-cell_type	NOUN	B
/macrophages	B-cell_type	NOUN	B
are	O	AUX	O
partially	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
delineate	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
HIV-infected	O	ADJ	B
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
focused	O	VERB	O
on	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
I	O	NOUN	O
kappa	O	NOUN	O
B	O	NOUN	O
molecules	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
parallels	O	VERB	O
the	O	DET	O
increased	O	VERB	B
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
synthesis	O	NOUN	O
secondary	O	ADJ	B
to	O	PART	I
increased	O	VERB	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
gene	O	NOUN	O
transcription	O	NOUN	O
,	O	PUNCT	O
i.e.	O	X	O
,	O	PUNCT	O
increased	O	VERB	B
RNA	O	NOUN	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
its	O	PRON	O
promoter-enhancer	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
persistent	O	ADJ	B
HIV	O	NOUN	B
infection	O	NOUN	I
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
provides	O	VERB	O
a	O	DET	O
useful	O	ADJ	O
model	O	NOUN	B
with	O	ADP	O
which	O	DET	O
to	O	PART	O
study	O	VERB	B
concomitant	O	ADJ	B
modifications	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
molecules	I-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
therapeutic	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
various	O	ADJ	O
diseases	O	NOUN	B
including	O	VERB	O
leukemia	O	NOUN	B
,	O	PUNCT	O
depends	O	VERB	O
on	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
HIV-1	B-protein	NOUN	B
protease	I-protein	NOUN	I
may	O	AUX	O
cleave	O	VERB	B
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
precursor	O	NOUN	B
to	O	PART	O
its	O	PRON	O
active	O	ADJ	B
form	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
limited	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
HIV	B-protein	NOUN	B
protease	I-protein	NOUN	I
appears	O	VERB	O
unlikely	O	ADJ	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
virus	O	NOUN	B
expression	O	NOUN	B
or	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


Enhancement	O	NOUN	B
of	O	ADP	O
IFNA	B-protein	NOUN	B
synthesis	O	NOUN	B
observed	O	VERB	O
upon	O	SCONJ	O
HIV-1	O	NOUN	B
infection	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
significant	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
for	O	ADP	O
a	O	DET	O
period	O	NOUN	B
of	O	ADP	O
at	O	ADV	O
least	O	ADV	O
30	O	NUM	O
days	O	NOUN	B
.	O	PUNCT	O


Chromosomal	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	O
two	O	NUM	O
KOX	B-DNA	NOUN	B
zinc	I-DNA	NOUN	B
finger	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
on	O	ADP	O
chromosome	B-DNA	NOUN	B
bands	I-DNA	NOUN	I
7q21-q22	B-DNA	NOUN	I
.	O	PUNCT	O


Pulse-field	O	ADJ	B
gel	O	NOUN	I
electrophoresis	O	NOUN	I
(	O	PUNCT	O
PFGE	O	NOUN	B
)	O	PUNCT	O
analysis	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
physically	O	ADV	B
located	O	ADJ	O
within	O	ADP	O
a	O	DET	O
DNA	B-DNA	NOUN	B
fragment	I-DNA	NOUN	I
of	O	ADP	O
250	B-DNA	NUM	O
kb	I-DNA	NOUN	O
.	O	PUNCT	O


From	O	ADP	O
the	O	DET	O
present	O	ADJ	O
and	O	CCONJ	O
previous	O	ADJ	O
data	O	NOUN	B
,	O	PUNCT	O
eighteen	O	NUM	O
different	O	ADJ	O
KOX	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
have	O	AUX	O
been	O	AUX	O
located	O	ADJ	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
by	O	ADP	O
two	O	NUM	O
within	O	ADP	O
nine	O	NUM	O
DNA	B-DNA	NOUN	B
fragments	I-DNA	NOUN	I
of	O	ADP	O
200	O	NUM	O
to	O	PART	O
580	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O


Mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
from	O	ADP	O
young	O	ADJ	B
or	O	CCONJ	O
elderly	O	ADJ	B
persons	O	NOUN	I
were	O	AUX	O
sham-exposed	O	VERB	B
or	O	CCONJ	O
exposed	O	VERB	B
to	O	PART	I
influenza	O	NOUN	B
virus	O	NOUN	I
for	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
24	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
72	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


Immunofluorescent	O	ADJ	B
staining	O	NOUN	I
and	O	CCONJ	O
flow	O	NOUN	B
cytometric	O	ADJ	I
analysis	O	NOUN	I
were	O	AUX	O
then	O	ADV	O
used	O	VERB	O
to	O	PART	O
detect	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
producing	O	VERB	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
regulating	I-protein	NOUN	O
proteins	I-protein	NOUN	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
failure	O	NOUN	B
of	O	ADP	O
virus-exposed	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
to	O	PART	O
produce	O	VERB	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
could	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
illness	O	NOUN	B
due	O	ADJ	O
to	O	PART	O
influenza	O	NOUN	B
virus	O	NOUN	I
in	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
by	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
correlates	O	VERB	O
with	O	ADP	O
cellular	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptors	I-protein	NOUN	I
.	O	PUNCT	O


DESIGN	O	NOUN	O
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
all-trans	O	ADJ	B
and	O	CCONJ	O
9-cis	O	ADJ	B
RA	O	NOUN	I
on	O	ADP	O
HIV-1	O	NOUN	B
production	O	NOUN	B
in	O	ADP	O
T-lymphoid	B-cell_line	NOUN	B
(	O	PUNCT	O
H9	B-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
CEM	I-cell_line	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
monocytoid	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
U937	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
THP-1	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
was	O	AUX	O
measured	O	VERB	O
during	O	ADP	O
acute	O	ADJ	B
and	O	CCONJ	O
chronic	O	ADJ	B
infection	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
retinoids	O	NOUN	B
had	O	AUX	O
weak	O	ADJ	B
or	O	CCONJ	O
no	O	DET	O
stimulatory	O	ADJ	B
effects	O	NOUN	I
on	O	ADP	O
HIV	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
T-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
RAR	O	NOUN	O
alpha	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
unchanged	O	ADJ	B
in	O	ADP	O
H9	B-cell_line	NOUN	B
and	O	CCONJ	O
CEM	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
elevated	O	ADJ	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
after	O	ADP	O
PMA	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
RA	O	NOUN	B
on	O	ADP	O
HIV-1	O	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
cell-type-dependent	O	ADJ	B
and	O	CCONJ	O
partially	O	ADV	O
correlated	O	VERB	B
with	O	ADP	O
cellular	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
RARs	B-protein	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
activities	O	NOUN	O
p56lck	B-protein	NOUN	B
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
are	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
intact	O	ADJ	B
cells	O	NOUN	I
by	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
,	O	PUNCT	O
they	O	PRON	O
are	O	AUX	O
likely	O	ADJ	O
targets	O	NOUN	B
for	O	ADP	O
GSSG	O	NOUN	B
action	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effector	O	NOUN	B
phase	O	NOUN	I
of	O	ADP	O
cytotoxic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
responses	O	NOUN	O
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
-dependent	O	ADJ	O
functions	O	NOUN	B
are	O	AUX	O
inhibited	O	VERB	B
even	O	ADV	O
by	O	ADP	O
a	O	DET	O
partial	O	ADJ	B
depletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
GSH	O	NOUN	B
pool	O	NOUN	B
.	O	PUNCT	O


T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
renal	O	ADJ	B
cell	O	NOUN	I
carcinoma	O	NOUN	I
patients	O	NOUN	B
exhibit	O	VERB	O
an	O	DET	O
abnormal	O	ADJ	B
pattern	O	NOUN	O
of	O	ADP	O
kappa	O	NOUN	O
B-specific	O	ADJ	O
DNA-binding	O	ADJ	O
activity	O	NOUN	O
:	O	PUNCT	O
a	O	DET	O
preliminary	O	ADJ	B
report	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
kappa	O	NOUN	B
B	O	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
unstimulated	B-cell_type	ADJ	B
patient	I-cell_type	NOUN	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
observed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
normal	O	ADJ	O
individuals	O	NOUN	B
that	O	PRON	O
had	O	AUX	O
been	O	AUX	O
activated	O	VERB	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
abnormality	O	NOUN	B
in	O	ADP	O
kappa	O	NOUN	O
B-binding	O	ADJ	O
activity	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
is	O	AUX	O
that	O	SCONJ	O
RelA	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Rel	B-protein	NOUN	B
homology	I-protein	NOUN	I
family	I-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
induced	O	VERB	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
following	O	VERB	O
activation	O	NOUN	B
.	O	PUNCT	O


Hemoglobin	B-protein	NOUN	B
switching	O	NOUN	I
in	O	ADP	O
humans	O	NOUN	B
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ratio	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
high	O	ADJ	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
normal	O	ADJ	O
adult	O	ADJ	O
erythroid	O	ADJ	B
differentiation	O	NOUN	O
.	O	PUNCT	O


MATERIALS	O	NOUN	O
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
work	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
cultured	O	VERB	B
erythroid	B-cell_type	ADJ	I
progenitors	I-cell_type	NOUN	I
derived	O	VERB	O
from	O	ADP	O
cord	O	NOUN	B
blood	O	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
fetal	O	ADJ	B
livers	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
from	O	ADP	O
beta	O	NOUN	B
zero-thalassemia	O	ADJ	I
patients	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
cultures	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
beta	O	NOUN	B
zero-thalassemia	O	ADJ	I
patients	O	NOUN	B
without	O	ADP	O
high	O	ADJ	B
HbF	B-protein	NOUN	B
,	O	PUNCT	O
``	O	PUNCT	O
adult	O	ADJ	B
''	O	PUNCT	O
pattern	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


Our	O	PRON	O
studies	O	NOUN	B
also	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
under	O	ADP	O
anemic	O	ADJ	B
stress	O	NOUN	I
,	O	PUNCT	O
recruitment	O	NOUN	B
of	O	ADP	O
fetal	B-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	I
may	O	AUX	O
occur	O	VERB	O
in	O	ADP	B
adulthood	O	NOUN	I
.	O	PUNCT	O


Accompanying	O	VERB	O
the	O	DET	O
rapid	O	ADJ	O
turnover	O	NOUN	B
of	O	ADP	O
the	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
protein	I-protein	NOUN	I
is	O	AUX	O
simultaneous	O	ADJ	B
translocation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B-related	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
to	O	PART	O
nuclei	O	NOUN	B
of	O	ADP	O
adhered	O	VERB	B
monocytes	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
interactive	O	ADJ	B
mechanisms	O	NOUN	B
regulate	O	VERB	O
monocytic	B-RNA	ADJ	B
I	I-RNA	NOUN	I
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
alpha/MAD-3	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
intracellular	B-protein	ADJ	B
dioxin	I-protein	NOUN	B
receptor	I-protein	NOUN	I
mediates	O	VERB	O
signal	O	NOUN	B
transduction	O	NOUN	I
by	O	ADP	O
dioxin	O	NOUN	B
and	O	CCONJ	O
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
ligand-activated	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PAS	B-protein	NOUN	B
domain	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
constitutive	O	ADJ	B
dimerization	O	NOUN	O
with	O	ADP	O
Arnt	B-protein	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
not	O	PART	O
possible	O	ADJ	O
to	O	PART	O
reconstitute	O	VERB	B
dioxin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
function	O	NOUN	O
with	O	ADP	O
proteins	O	NOUN	B
expressed	O	VERB	B
in	O	ADP	O
wheat	O	NOUN	B
germ	O	NOUN	B
lysate	O	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
ligand-binding	O	ADJ	B
activity	O	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
hsp90	B-protein	NOUN	B
,	O	PUNCT	O
bHLH-	O	NOUN	B
hsp90	B-protein	NOUN	B
interaction	O	NOUN	B
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
but	O	CCONJ	O
not	O	PART	O
for	O	ADP	O
dimerization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
.	O	PUNCT	O


Aspirin-like	O	ADJ	B
drugs	O	NOUN	I
(	O	PUNCT	O
ALD	O	NOUN	B
)	O	PUNCT	O
induce	O	VERB	B
calcium	O	NOUN	B
mobilization	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
essential	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
induce	O	VERB	B
the	O	DET	O
biosynthesis	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
depended	O	VERB	O
on	O	ADP	O
calcium	O	NOUN	B
mobilization	O	NOUN	I
and	O	CCONJ	O
PKC	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
involving	O	VERB	O
PKC	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
calcium	O	NOUN	B
mobilization	O	NOUN	I
and	O	CCONJ	O
ras	B-protein	NOUN	B
activation	O	NOUN	I
combine	O	VERB	O
to	O	PART	O
provide	O	VERB	O
the	O	DET	O
necessary	O	ADJ	O
components	O	NOUN	B
for	O	ADP	O
production	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
are	O	AUX	O
human	O	ADJ	B
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	O
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
same	O	ADJ	O
DNA	O	NOUN	B
element	O	NOUN	I
but	O	CCONJ	O
activate	O	VERB	B
distinct	O	ADJ	O
sets	O	NOUN	O
of	O	ADP	O
genes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
death	O	NOUN	I
in	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
glucocorticoids	O	NOUN	B
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
earliest	O	ADJ	O
and	O	CCONJ	O
most	O	ADV	O
thoroughly	O	ADV	O
studied	O	VERB	O
models	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Interleukin-2	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
stat3	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


An	O	DET	O
early	O	ADJ	B
biochemical	O	ADJ	B
event	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
interleukin-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
several	O	ADJ	O
intracellular	O	ADJ	B
substrates	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
induced	O	ADJ	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
stat3	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
newly	O	ADV	O
identified	O	VERB	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
family	I-protein	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
had	O	AUX	O
an	O	DET	O
apparent	O	ADJ	B
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
84	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
was	O	AUX	O
not	O	PART	O
recognized	O	VERB	O
by	O	ADP	O
stat3	B-protein	NOUN	B
or	O	CCONJ	O
stat1	B-protein	NOUN	B
mAb	I-protein	NOUN	O
or	O	CCONJ	O
antisera	O	NOUN	B
.	O	PUNCT	O


Tax	O	NOUN	B
acts	O	VERB	O
indirectly	O	ADV	O
by	O	ADP	O
inducing	O	VERB	B
or	O	CCONJ	O
modifying	O	VERB	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
host	O	NOUN	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
enhancer-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
prior	O	ADJ	O
in	O	X	B
vitro	O	X	I
studies	O	NOUN	I
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
a	O	DET	O
fraction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phosphorylated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
remains	O	VERB	O
physically	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
in	O	X	B
vivo	O	X	I
but	O	CCONJ	O
is	O	AUX	O
subject	O	ADJ	O
to	O	PART	O
rapid	O	ADJ	O
degradation	O	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
promoting	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
active	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	X	B
vivo	O	X	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
multiple	O	ADJ	B
phosphorylations	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
TNF-alpha	O	NOUN	B
rapidly	O	ADV	O
induced	O	VERB	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
primarily	O	ADV	O
of	O	ADP	O
p50-p65	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
c-rel	B-protein	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
precursors	O	NOUN	I
and	O	CCONJ	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
became	O	VERB	O
strongly	O	ADV	O
phosphorylated	O	VERB	B
with	O	ADP	O
the	O	DET	O
same	O	ADJ	O
kinetics	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
the	O	DET	O
inducible	O	ADJ	B
phosphorylation	O	NOUN	B
after	O	ADP	O
stimulation	O	NOUN	B
,	O	PUNCT	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
containing	O	VERB	O
constitutive	O	ADJ	B
nuclear	O	ADJ	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
revealed	O	VERB	O
constitutively	O	ADV	B
phosphorylated	O	VERB	O
p65	B-protein	NOUN	O
and	O	CCONJ	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
model	O	NOUN	B
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
p105	B-protein	NOUN	B
impedes	O	VERB	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
before	O	ADP	O
for	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
induction	O	NOUN	B
by	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
assumed	O	VERB	O
to	O	PART	O
be	O	AUX	O
triggered	O	VERB	B
by	O	ADP	I
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediates	O	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
coincided	O	VERB	O
with	O	ADP	O
incorporation	O	NOUN	B
of	O	ADP	O
phosphate	O	NOUN	B
into	O	ADP	O
the	O	DET	O
same	O	ADJ	O
subunits	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
modified	O	VERB	B
after	O	ADP	O
stimulation	O	NOUN	B
by	O	ADP	O
TNF-alpha	B-protein	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
well	O	ADV	O
documented	O	VERB	B
that	O	SCONJ	O
treatment	O	NOUN	B
of	O	ADP	O
serum-grown	B-cell_line	ADJ	B
HL60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
all-trans	O	ADJ	B
RA	O	NOUN	I
)	O	PUNCT	O
induces	O	VERB	O
neutrophil	B-cell_type	NOUN	B
differentiation	O	NOUN	O
,	O	PUNCT	O
whereas	O	SCONJ	O
treatment	O	NOUN	B
with	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25	O	NUM	O
dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
(	O	PUNCT	O
D3	O	NOUN	B
)	O	PUNCT	O
induces	O	VERB	B
differentiation	O	NOUN	B
towards	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
serum-free	B-cell_line	ADJ	B
grown	I-cell_line	VERB	I
HL60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
5	O	NUM	O
x	O	CCONJ	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
all-trans	O	ADJ	B
RA	O	NOUN	B
or	O	CCONJ	O
9-cis	O	ADJ	O
RA	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
sub-optimal	O	ADJ	O
neutrophil	O	NOUN	B
differentiation	O	NOUN	O
(	O	PUNCT	O
up	O	ADV	O
to	O	PART	O
25	O	NUM	O
%	O	NOUN	O
mature	O	ADJ	B
cells	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Cross	O	NOUN	B
titration	O	NOUN	I
analyses	O	NOUN	I
of	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
9-cis	O	ADJ	B
RA	O	NOUN	I
and	O	CCONJ	O
D3	O	NOUN	B
on	O	ADP	O
HL60	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
differentiation	O	NOUN	O
were	O	AUX	O
undertaken	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
boundaries	O	NOUN	B
of	O	ADP	O
the	O	DET	O
concentrations	O	NOUN	B
of	O	ADP	O
each	O	DET	O
agent	O	NOUN	B
,	O	PUNCT	O
alone	O	ADV	O
and	O	CCONJ	O
in	O	ADP	O
combination	O	NOUN	B
,	O	PUNCT	O
that	O	PRON	O
give	O	VERB	O
rise	O	NOUN	O
to	O	PART	O
optimal	O	ADJ	B
neutrophil	O	NOUN	B
and	O	CCONJ	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
of	O	ADP	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
of	O	ADP	O
these	O	DET	O
DESTs	B-DNA	NOUN	B
,	O	PUNCT	O
GIG10	B-DNA	NOUN	B
and	O	CCONJ	O
GIG18	B-DNA	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
rapidly	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
dexamethasone	O	NOUN	B
within	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
thymocytes	I-cell_type	NOUN	B
after	O	ADP	O
infection	O	NOUN	B
by	O	ADP	O
EBV	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
during	O	ADP	O
infection	O	NOUN	B
by	O	ADP	O
EBV	O	NOUN	B
,	O	PUNCT	O
ligation	O	NOUN	B
of	O	ADP	O
CD2	B-protein	NOUN	B
caused	O	VERB	O
thymocytes	B-cell_type	NOUN	B
to	O	PART	O
proliferate	O	VERB	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
exogenous	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viral	O	ADJ	B
replicative	O	ADJ	O
pathway	O	NOUN	O
were	O	AUX	O
expressed	O	VERB	B
during	O	ADP	O
infection	O	NOUN	B
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
transcript	O	NOUN	B
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
encoding	O	VERB	B
the	O	DET	O
recently	O	ADV	O
characterized	O	VERB	B
RAZ	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
also	O	ADV	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
replicative	O	ADJ	B
infection	O	NOUN	I
.	O	PUNCT	O


Before	O	ADP	B
treatment	O	NOUN	B
,	O	PUNCT	O
at	O	ADP	O
regular	O	ADJ	O
intervals	O	NOUN	B
during	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
week	O	NOUN	B
and	O	CCONJ	O
finally	O	ADV	O
6	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
termination	O	NOUN	B
of	O	ADP	I
treatment	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
effects	O	NOUN	B
on	O	ADP	O
glucocorticoid	O	NOUN	B
receptor	O	NOUN	I
(	O	PUNCT	O
GR	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
methallothionein	O	NOUN	B
(	O	PUNCT	O
MTIIa	O	NOUN	B
)	O	PUNCT	O
mRNA	O	NOUN	B
expression	O	NOUN	O
levels	O	NOUN	O
were	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
using	O	VERB	O
a	O	DET	O
solution	O	NOUN	B
hybridization	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


Biphasic	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	I
by	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
:	O	PUNCT	O
role	O	NOUN	O
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


p50.c-rel	B-protein	NOUN	O
heterodimers	I-protein	NOUN	B
were	O	AUX	O
also	O	ADV	O
detected	O	VERB	B
bound	O	VERB	O
to	O	PART	O
this	O	DET	O
sequence	O	NOUN	B
at	O	ADP	O
early	O	ADJ	B
time	O	NOUN	I
points	O	NOUN	I
(	O	PUNCT	O
7-16	O	NUM	O
h	O	NOUN	O
;	O	PUNCT	O
early	O	ADV	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
both	O	DET	O
remained	O	VERB	O
active	O	ADJ	B
at	O	ADP	O
later	O	ADJ	O
time	O	NOUN	O
points	O	NOUN	O
(	O	PUNCT	O
40	O	NUM	O
h	O	NOUN	O
;	O	PUNCT	O
late	O	ADJ	O
)	O	PUNCT	O
after	O	ADP	O
activation	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
also	O	ADV	O
induced	O	VERB	B
c-rel	O	NOUN	B
and	O	CCONJ	O
p105/p50	O	NOUN	B
mRNA	O	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
p65	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
whose	O	DET	O
expression	O	NOUN	B
was	O	AUX	O
constitutive	O	ADJ	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
all	O	DET	O
those	O	DET	O
early	O	ADJ	B
and	O	CCONJ	O
late	O	ADJ	O
events	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
immediate	O	ADJ	B
ones	O	NOUN	O
,	O	PUNCT	O
were	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
neutralizing	O	VERB	O
anti-tumor	B-protein	ADJ	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	I-protein	PUNCT	O
TNF-alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


Cyclosporin	O	NOUN	B
A	O	NOUN	O
impaired	O	VERB	B
not	O	PART	O
only	O	ADV	O
early	O	ADJ	B
and	O	CCONJ	O
late	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
immediate	O	ADJ	O
events	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
addition	O	NOUN	O
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
prevented	O	VERB	B
all	O	DET	O
inhibition	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
three	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GC-box	B-DNA	NOUN	B
can	O	AUX	O
functionally	O	ADV	O
compensate	O	VERB	B
for	O	ADP	O
the	O	DET	O
GM-kappa	B-DNA	NOUN	B
B/GC-box	I-DNA	NOUN	B
region	I-DNA	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
GC-motif	O	NOUN	B
can	O	AUX	O
function	O	VERB	O
independently	O	ADV	O
of	O	ADP	O
the	O	DET	O
GM-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
motif	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
depletion	O	NOUN	B
of	O	ADP	O
Sp1	B-protein	NOUN	B
(	O	PUNCT	O
A1	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
specifically	O	ADV	O
decreases	O	VERB	B
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
activity	O	NOUN	I
on	O	ADP	O
GM-CSF	B-protein	NOUN	B
templates	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	O
DNA	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
element	I-DNA	NOUN	I
termed	O	VERB	O
the	O	DET	O
J	B-DNA	NOUN	O
element	I-DNA	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulated	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
was	O	AUX	O
recently	O	ADV	O
described	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
require	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
S	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
J	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
separated	O	VERB	O
by	O	ADP	O
10	O	NUM	O
bp	O	NOUN	O
for	O	ADP	O
optimal	O	ADJ	B
binding	O	NOUN	B
.	O	PUNCT	O


Separation	O	NOUN	B
of	O	ADP	O
oxidant-initiated	O	ADJ	B
and	O	CCONJ	O
redox-regulated	O	ADJ	B
steps	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
signal	O	NOUN	I
transduction	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
internal	O	ADJ	B
sites	O	NOUN	I
of	O	ADP	O
oxidant	O	ADJ	B
production	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
-stimulated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
since	O	SCONJ	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
and	O	CCONJ	O
phosphatase	O	NOUN	B
activities	O	NOUN	I
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
altered	O	VERB	O
by	O	ADP	O
oxidants	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
intracellular	O	ADJ	B
redox	O	NOUN	B
status	O	NOUN	I
controls	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
regulating	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
event	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
common	O	ADJ	O
step	O	NOUN	O
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
signal	O	NOUN	I
transduction	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


Alagille	O	NOUN	B
syndrome	O	NOUN	I
(	O	PUNCT	O
AGS	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
well-defined	O	ADJ	O
genetic	O	ADJ	B
entity	O	NOUN	I
assigned	O	VERB	B
to	O	PART	O
the	O	DET	O
short	B-DNA	ADJ	B
arm	I-DNA	NOUN	I
of	O	ADP	I
Chromosome	B-DNA	NOUN	I
(	I-DNA	PUNCT	I
Chr	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
20	I-DNA	NUM	O
by	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
observations	O	NOUN	B
of	O	ADP	O
AGS	O	NOUN	B
patients	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
microdeletions	O	NOUN	B
in	O	ADP	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
)	O	PUNCT	O
alpha	O	NOUN	O
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
inhibit	O	VERB	B
in	O	X	B
vitro	O	X	I
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
complex	O	NOUN	B
between	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
AP-1	B-protein	NOUN	I
/OAP	B-protein	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
specific	O	ADJ	O
binding	O	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
interference	O	NOUN	B
with	O	ADP	O
Oct-2	B-protein	NOUN	B
-dependent	O	ADJ	O
cis-regulatory	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
this	O	DET	O
AP-1	B-protein	NOUN	B
element	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
status	O	NOUN	B
of	O	ADP	O
X	B-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
inactivation	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
leukocytes	O	NOUN	I
from	O	ADP	O
obligate	O	ADJ	B
carriers	O	NOUN	B
of	O	ADP	O
XCID	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
from	O	ADP	O
the	O	DET	O
polymorphic	O	ADJ	B
,	O	PUNCT	O
short	O	ADJ	B
tandem	O	ADJ	I
repeats	O	NOUN	I
(	O	PUNCT	I
CAG	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
androgen	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
also	O	ADV	O
contains	O	VERB	O
a	O	DET	O
methylation-sensitive	B-DNA	ADJ	B
HpaII	I-DNA	NOUN	O
site	I-DNA	NOUN	O
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
XSCID	O	NOUN	B
,	O	PUNCT	O
X-chromosome	O	NOUN	B
inactivation	O	NOUN	B
in	O	ADP	O
obligate	O	ADJ	B
carriers	O	NOUN	B
of	O	ADP	O
XCID	O	NOUN	B
was	O	AUX	O
nonrandom	O	ADJ	B
in	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
TF	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
by	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
monocyte/macrophage	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
represents	O	VERB	O
an	O	DET	O
important	O	ADJ	O
mechanism	O	NOUN	B
underlying	O	VERB	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
fibrin	B-protein	NOUN	B
deposition	O	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
extravascular	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
neither	O	DET	O
of	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
reduced	O	VERB	B
LPS-stimulated	O	ADJ	B
TF	B-protein	NOUN	B
mRNA	O	NOUN	B
accumulation	O	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
suggesting	O	VERB	O
a	O	DET	O
posttranscriptional	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


Immunofluorescence	O	NOUN	B
studies	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
using	O	VERB	O
polyclonal	O	ADJ	B
anti-TF	B-protein	ADJ	B
antibody	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
N-acetyl-cysteine	O	NOUN	B
treatment	O	NOUN	B
prevented	O	VERB	B
the	O	DET	O
characteristic	O	ADJ	O
plasmalemmal	O	ADJ	B
localization	O	NOUN	O
of	O	ADP	O
TF	B-protein	NOUN	B
antigen	I-protein	NOUN	I
that	O	PRON	O
occurs	O	VERB	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
considered	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
antioxidants	O	NOUN	B
exert	O	VERB	O
their	O	PRON	O
effects	O	NOUN	B
by	O	ADP	I
impairing	O	VERB	B
translation	O	NOUN	B
and/or	O	CCONJ	O
by	O	ADP	O
causing	O	VERB	O
degradation	O	NOUN	B
of	O	ADP	O
newly	O	ADV	O
translated	B-protein	VERB	O
protein	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
posttranscriptional	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
antioxidants	O	NOUN	B
on	O	ADP	O
TF	B-protein	NOUN	B
expression	O	NOUN	B
data	O	NOUN	B
suggests	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
mechanism	O	NOUN	B
whereby	O	SCONJ	O
these	O	DET	O
agents	O	NOUN	B
might	O	AUX	O
modulate	O	VERB	B
monocyte	B-cell_type	NOUN	B
/macrophage	B-cell_type	NOUN	O
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
detected	O	VERB	B
a	O	DET	O
specific	O	ADJ	O
nuclear	B-protein	ADJ	B
protein	I-protein	NOUN	I
complex	I-protein	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
element	O	NOUN	B
and	O	CCONJ	O
show	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B1	I-protein	NOUN	I
(	O	PUNCT	O
p50	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
part	O	NOUN	O
of	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
similar	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
by	O	ADP	O
TG	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
TG	O	NOUN	B
and	O	CCONJ	O
PMA	O	NOUN	B
exhibited	O	VERB	O
a	O	DET	O
synergistic	O	ADJ	B
action	O	NOUN	I
on	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
TG	O	NOUN	B
and	O	CCONJ	O
PMA	O	NOUN	B
induce	O	VERB	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
through	O	ADP	O
distinct	O	ADJ	O
pathways	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
agent	O	NOUN	B
,	O	PUNCT	O
17	O	NUM	O
beta-estradiol	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
17	O	NUM	O
alpha-estradiol	O	NOUN	B
,	O	PUNCT	O
significantly	O	ADV	O
reduced	O	VERB	O
PMNs	B-cell_type	NOUN	B
chemotaxis	O	NOUN	B
to	O	PART	O
FMLP	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
(	O	PUNCT	O
control	O	NOUN	B
vs	O	CCONJ	O
estrogen	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
-10	O	NUM	B
)	O	PUNCT	O
-	O	PUNCT	O
(	O	PUNCT	O
-6	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Pre-incubation	O	NOUN	B
with	O	ADP	O
clomiphene	O	NOUN	B
or	O	CCONJ	O
tamoxifen	O	NOUN	B
which	O	DET	O
are	O	AUX	O
estrogen	O	NOUN	B
receptor	O	NOUN	I
antagonists	O	NOUN	I
,	O	PUNCT	O
eliminated	O	VERB	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
17	O	NUM	O
beta-estradiol	O	NOUN	B
on	O	ADP	O
the	O	DET	O
chemotaxis	O	NOUN	B
of	O	ADP	O
PMNs	B-cell_type	NOUN	B
,	O	PUNCT	O
restoring	O	VERB	B
it	O	PRON	O
to	O	ADP	O
the	O	DET	O
control	O	NOUN	B
level	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
estradiol	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
plasma	I-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
PMNs	B-cell_type	NOUN	B
were	O	AUX	O
drawn	O	VERB	O
,	O	PUNCT	O
showed	O	VERB	O
a	O	DET	O
close	O	ADJ	O
,	O	PUNCT	O
inverse	O	ADJ	B
correlation	O	NOUN	B
with	O	ADP	O
the	O	DET	O
PMNs	B-cell_type	NOUN	B
chemotaxis	O	NOUN	B
to	O	PART	O
FMLP	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
-0.821	O	NUM	O
p	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Competition	O	NOUN	B
and	O	CCONJ	O
supershift	O	NOUN	B
experiments	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
Mono	B-protein	NOUN	B
B	I-protein	NOUN	I
contains	O	VERB	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
polyomavirus	B-protein	NOUN	B
enhancer-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
2/core-binding	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
PEBP2/CBF	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	O
,	I-protein	PUNCT	O
which	O	DET	O
includes	O	VERB	O
the	O	DET	O
AML1	O	NOUN	B
gene	O	NOUN	I
product	O	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
Mono	B-protein	NOUN	B
A	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
distinct	O	ADJ	O
complex	O	NOUN	B
preferentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
monocyte/B-cell-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
PU.1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
Mono	B-protein	NOUN	B
A	I-protein	NOUN	I
and	I-protein	CCONJ	O
Mono	I-protein	NOUN	B
B	I-protein	NOUN	I
protein	I-protein	NOUN	I
complexes	I-protein	NOUN	I
act	O	VERB	O
in	O	ADP	O
concert	O	NOUN	O
to	O	PART	O
regulate	O	VERB	B
monocyte-specific	O	ADJ	B
transcription	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CSF-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
simultaneous	O	ADJ	B
addition	O	NOUN	O
of	O	ADP	O
50-500	O	NUM	O
microM	O	NOUN	O
PDTC	O	NOUN	B
with	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
blocked	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
completely	O	ADV	O
abrogated	O	VERB	O
both	O	CCONJ	O
morphologically	O	ADV	B
apoptotic	O	ADJ	B
changes	O	NOUN	O
and	O	CCONJ	O
internucleosomal	O	ADJ	B
DNA	O	NOUN	O
fragmentation	O	NOUN	O
for	O	ADP	O
up	O	ADV	O
to	O	PART	O
6	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
PDTC	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
etoposide	O	NOUN	B
-and	O	NOUN	O
dexamethasone-induced	O	ADJ	B
apoptosis	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
thymocytes	I-cell_type	NOUN	B
at	O	ADP	O
a	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
1-10	O	NUM	O
microM	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
family	O	NOUN	B
of	O	ADP	O
serine	B-protein	NOUN	B
proteases	I-protein	NOUN	I
expressed	O	VERB	B
exclusively	O	ADV	O
in	O	ADP	O
myelo-	O	ADJ	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
specifically	O	ADV	O
processes	O	VERB	B
the	O	DET	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
subunit	I-protein	NOUN	I
p65	I-protein	NOUN	I
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
may	O	AUX	O
impair	O	VERB	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
replication	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


``	B-cell_line	PUNCT	O
Plus	I-cell_line	CCONJ	B
''	I-cell_line	PUNCT	I
clones	I-cell_line	NOUN	B
replicated	O	VERB	B
the	O	DET	O
virus	O	NOUN	B
efficiently	O	ADV	B
,	O	PUNCT	O
whereas	O	SCONJ	O
``	B-cell_line	PUNCT	O
minus	I-cell_line	NOUN	B
''	I-cell_line	PUNCT	O
clones	I-cell_line	NOUN	B
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


We	O	PRON	O
examined	O	VERB	O
these	O	DET	O
clones	O	NOUN	B
for	O	ADP	O
differences	O	NOUN	B
in	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
activity	O	NOUN	B
which	O	DET	O
might	O	AUX	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
observed	O	VERB	B
phenomenon	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
p65	B-protein	NOUN	B
subunit	I-protein	NOUN	I
was	O	AUX	O
COOH-terminally	O	ADV	B
truncated	O	VERB	I
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
immunoprecipitation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
in	O	X	B
vitro	O	X	I
cleavage	O	NOUN	B
of	O	ADP	O
p65	B-protein	NOUN	B
by	O	ADP	O
purified	O	VERB	B
elastase	B-protein	NOUN	I
and	O	CCONJ	O
cathepsin	B-protein	NOUN	B
G	I-protein	NOUN	I
.	O	PUNCT	O


Biochemical	O	ADJ	B
studies	O	NOUN	I
demonstrate	O	VERB	O
that	O	SCONJ	O
OBF-1	B-protein	NOUN	B
has	O	AUX	O
no	O	DET	O
intrinsic	O	ADJ	O
DNA-binding	O	ADJ	B
activity	O	NOUN	I
and	O	CCONJ	O
recognizes	O	VERB	O
the	O	DET	O
POU	B-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
those	O	DET	O
of	O	ADP	O
Oct-4	B-protein	NOUN	B
and	O	CCONJ	O
Oct-6	B-protein	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	B
by	O	ADP	O
intracellular	O	ADJ	B
glutathione	O	NOUN	B
levels	O	NOUN	O
and	O	CCONJ	O
by	O	ADP	O
variations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
extracellular	O	ADJ	B
cysteine	O	NOUN	B
supply	O	NOUN	O
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
genistein	O	NOUN	B
,	O	PUNCT	O
another	O	DET	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
totally	O	ADV	O
abolished	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
second	O	ADJ	O
peak	O	NOUN	O
of	O	ADP	O
junB	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
whereas	O	SCONJ	O
it	O	PRON	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
peak	O	NOUN	O
.	O	PUNCT	O


Enhanced	O	VERB	B
responsiveness	O	NOUN	B
to	O	PART	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
unique	O	ADJ	B
phenotype	O	NOUN	B
of	O	ADP	O
simian	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
variant	O	ADJ	B
SIVsmmPBj14	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
level	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
is	O	AUX	O
variable	O	ADJ	B
and	O	CCONJ	O
is	O	AUX	O
frequently	O	ADV	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
lower	O	ADJ	O
in	O	ADP	O
the	O	DET	O
more	O	ADV	O
mature	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
SCL	O	NOUN	B
in	O	ADP	O
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
burst-forming	I-cell_type	ADJ	I
unit-erythroid	I-cell_type	NOUN	I
(	O	PUNCT	I
BFU-E	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
Steel	B-protein	NOUN	B
factor	I-protein	NOUN	I
on	O	ADP	O
SCL	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
proliferating	B-cell_type	VERB	B
erythroid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


BFU-E-derived	B-cell_line	ADJ	B
colonies	I-cell_line	NOUN	B
increase	O	VERB	B
progressively	O	ADV	O
in	O	ADP	O
size	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
number	O	NOUN	I
,	O	PUNCT	O
from	O	ADP	O
day	O	NOUN	B
7	O	NUM	O
to	O	PART	O
day	O	NOUN	B
14	O	NUM	O
of	O	ADP	O
culture	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
greatest	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
colony	O	NOUN	B
size	O	NOUN	I
(	O	PUNCT	O
10-fold	O	ADJ	O
expansion	O	NOUN	B
)	O	PUNCT	O
occurring	O	VERB	O
between	O	ADP	O
day	O	NOUN	B
7	O	NUM	O
and	O	CCONJ	O
day	O	NOUN	B
10	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
SCL	B-protein	NOUN	B
protein	O	NOUN	I
levels	O	NOUN	O
in	O	ADP	O
early	O	ADJ	O
erythroid	B-cell_type	ADJ	B
precursors	I-cell_type	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
Steel	B-protein	NOUN	B
factor	I-protein	NOUN	I
suggests	O	VERB	O
one	O	NUM	O
mechanism	O	NOUN	B
through	O	ADP	O
which	O	DET	O
Steel	B-protein	NOUN	B
factor	I-protein	NOUN	I
may	O	AUX	O
enhance	O	VERB	O
normal	O	ADJ	O
erythroid	O	ADJ	B
proliferation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
implicate	O	VERB	O
C/EBP	B-protein	NOUN	B
beta	I-protein	NOUN	I
as	O	ADP	O
an	O	DET	O
important	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
by	O	ADP	O
myelomonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


RNAase	B-protein	NOUN	B
protection	O	NOUN	B
assays	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MMP9	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
unique	O	ADJ	O
to	O	PART	O
infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
increased	O	VERB	B
MMP9	B-protein	NOUN	B
mRNA	O	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


Growth	O	NOUN	B
arrest	O	NOUN	I
is	O	AUX	O
reversible	O	ADJ	O
for	O	ADP	O
G1/G0	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
as	O	ADP	O
indicated	O	VERB	O
by	O	ADP	O
the	O	DET	O
sequential	O	ADJ	B
accumulation	O	NOUN	B
and	O	CCONJ	O
modification	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
cycle	I-protein	NOUN	I
regulating	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


RJ	B-cell_line	NOUN	B
2.2.5	I-cell_line	NUM	I
is	O	AUX	O
a	O	DET	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
mutant	I-cell_line	NOUN	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
Burkitt	B-cell_line	NOUN	B
lymphoma	I-cell_line	NOUN	I
Raji	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
which	O	DET	O
is	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
the	O	DET	O
AIR-1	O	NOUN	B
locus	O	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


Correlation	O	NOUN	B
of	O	ADP	O
differentiation-inducing	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
retinoids	O	NOUN	B
on	O	ADP	O
human	B-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
HL-60	B-cell_line	NOUN	B
and	O	CCONJ	O
NB4	B-cell_line	NOUN	B
.	O	PUNCT	O


A	O	DET	O
good	O	ADJ	O
linear	O	ADJ	O
correlation	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
r	O	NOUN	O
value	O	NOUN	O
of	O	ADP	O
0.91	O	NUM	O
,	O	PUNCT	O
between	O	ADP	O
the	O	DET	O
ED50	O	NOUN	B
values	O	NOUN	B
for	O	ADP	O
the	O	DET	O
differentiation-inducing	O	ADJ	B
activity	O	NOUN	I
towards	O	ADP	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
that	O	DET	O
towards	O	ADP	O
NB4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
found	O	VERB	O
.	O	PUNCT	O


J	B-cell_line	NOUN	O
delta	I-cell_line	NOUN	O
K	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
exhibited	O	VERB	O
very	O	ADV	O
low	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
HIV	O	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
occupancy	O	NOUN	B
of	O	ADP	O
this	O	DET	O
site	O	NOUN	B
is	O	AUX	O
observed	O	VERB	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
H9	B-cell_line	NOUN	B
T-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Antigenic	O	ADJ	B
specificities	O	NOUN	I
of	O	ADP	O
human	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
recovered	O	VERB	O
from	O	ADP	O
recurrent	O	ADJ	B
genital	O	ADJ	O
herpes	O	NOUN	O
simplex	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
2	O	NUM	O
lesions	O	NOUN	B
.	O	PUNCT	O


Each	O	DET	O
of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
four	O	NUM	O
patients	O	NOUN	B
also	O	ADV	O
yielded	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
type-specific	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clone	I-cell_line	NOUN	I
reactive	O	ADJ	B
with	O	ADP	O
an	O	DET	O
HSV-2	O	NOUN	B
epitope	O	NOUN	B
mapping	O	VERB	I
to	O	PART	O
approximately	O	ADV	O
0.67	O	NUM	O
to	O	PART	O
0.73	O	NUM	O
map	O	NOUN	B
units	O	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
deficient	O	ADJ	B
in	O	ADP	O
CD3	O	NOUN	B
or	O	CCONJ	O
CD45	O	NOUN	B
expression	O	NOUN	B
also	O	ADV	O
gave	O	VERB	O
impaired	O	ADJ	B
UV	O	NOUN	B
responses	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
redox	O	NOUN	B
changes	O	NOUN	O
in	O	X	B
vivo	O	X	I
on	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
human	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
,	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
and	O	CCONJ	O
KG-1	B-cell_line	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
cells	O	NOUN	B
were	O	AUX	O
preincubated	O	VERB	B
with	O	ADP	O
dihydrolipoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
0.2	O	NUM	O
mM	O	NOUN	O
)	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
c-fos	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
suppressed	O	VERB	B
at	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
TPA	O	NOUN	B
(	O	PUNCT	O
0.5	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
whereas	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
preincubation	O	NOUN	B
of	O	ADP	O
alpha-lipoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
0.2	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
was	O	AUX	O
enhanced	O	VERB	B
at	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
events	O	NOUN	B
are	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
marked	O	ADJ	O
increases	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
RAG-1	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
RAG-2	I-RNA	NOUN	B
RNAs	I-RNA	NOUN	I
.	O	PUNCT	O


